Rentokil Initial PLC 6-K, filed Jul 27, 2023
Rentokil Initial PLC (RTO)
6-K
2023-07-27
For: 2023-07-27
View Original
Added on
April 11, 2026
About this 6-K
Rentokil Initial PLC filed this 6-K on July 27, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of July 2023
Commission File Number: 001-41524
Rentokil Initial plc
(Registrant’s name)
Compass House
Manor Royal
Crawley
West Sussex RH10 9PY
United Kingdom
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ☐
|
2023
Interim Results dated 27 July 2023
|
|
2023 Interim Results
Strong
operational and financial performance: Organic Revenue¹ growth of 5.9%;
excellent momentum in bolt-on M&A with increased spend
expectation for full year
Effective
delivery on Terminix integration plan; cost synergies firmly on
track
|
Financial Results¹
|
AER
|
|
CER
|
||||
|
£m
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
|
|
Revenue
|
2,671
|
1,572
|
69.9%
|
|
2,666
|
1,613
|
65.3%
|
|
Adjusted
EBITDA
|
602
|
350
|
72.0%
|
|
|
|
|
|
Adjusted
Operating Profit
|
437
|
233
|
88.0%
|
|
434
|
239
|
81.7%
|
|
Adjusted
Profit before Tax
|
377
|
226
|
67.3%
|
|
383
|
229
|
66.9%
|
|
Free
Cash Flow
|
229
|
151
|
51.7%
|
|
|
|
|
|
Diluted
Adjusted EPS
|
11.41p
|
9.45p
|
20.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statutory Results
|
|
|
|
|
|
|
|
|
Revenue
|
2,671
|
1,572
|
69.9%
|
|
|
|
|
|
Operating
Profit
|
304
|
170
|
79.3%
|
|
|
|
|
|
Profit
before Tax
|
240
|
162
|
48.1%
|
|
|
|
|
|
EPS
|
7.35p
|
6.67p
|
10.2%
|
|
|
|
|
|
Dividend
Per Share
|
2.75p
|
2.40p
|
14.6%
|
|
|
|
|
2023 Interim Highlights (Unless otherwise stated, all
financials are presented at constant exchanges rates and Organic
Revenue growth figures exclude COVID disinfection.)
|
●
|
Revenue up 65.3%, reflecting the benefit of M&A,
including Terminix. Strong Organic Revenue growth of
5.9%, reflecting growth across all regions, and driven by
resilient underlying demand and continued effective pricing.
Statutory Revenue
up 69.9% to £2,671m at AER
|
|
|
|
–
|
Organic
Revenue growth of 4.1% in North America, achieved alongside the
start of the integration pilot programme and exit of 64 branches;
Organic Revenue growth of 4.8% in North America Pest Control
services despite lower industry-wide lead flow from residential and
termite customers
|
|
|
–
|
Organic
Revenue up 11.1% in Europe, the Group’s second largest
region
|
|
|
|
Strong
Organic Revenue growth across all business categories: 5.6% in Pest
Control; 5.2% in Hygiene and Wellbeing; and 16.3% in France
Workwear
|
|
●
|
Adjusted Operating Profit increased 81.7%; 67.3% growth in Adjusted
PBT at AER despite a £6m FX headwind. Statutory PBT up 48.1%
to £240m at AER
|
|
|
|
–
|
Group
Adjusted Operating Margin up 150bps to 16.3%2, with margin
expansion in Pest Control and France Workwear partly offset by
Hygiene & Wellbeing, impacted in the half by COVID boosted
prior year comparators
|
|
|
–
|
North
America Adjusted Operating Margin up 250bps to 18.5%, underpinned
by the delivery of Terminix synergies
|
|
|
–
|
Sustained
strong price progression across all regions, accompanied by good
customer retention
|
|
●
|
Diluted Adjusted EPS up 20.7% to 11.41p
|
|
|
●
|
Free Cash Flow of £229m due to the timing of interest
payments, leading to 83.0% Adjusted Free Cash Flow conversion in
H1, as expected. Guidance on Adjusted FCF conversion in FY 23
maintained at 80-90%
|
|
|
●
|
Effective reduction in leverage with pro forma net debt to Adjusted
EBITDA of 2.8x at 30 June 2023 (FY 22: 3.2x). Net debt at
£3.27bn (FY 22 £3.30bn)
|
|
|
●
|
Strong progress on Terminix integration, tracking cost synergy
guidance
|
|
|
|
–
|
$37m
pre-tax net P&L cost synergies achieved in H1 23, on track to
deliver total of $60m year over year in FY 23
|
|
|
–
|
Terminix
colleague retention up strongly, 3.7ppts to 67.7%
|
|
●
|
Continued excellent momentum in value-creating M&A
|
|
|
|
–
|
24
acquisitions completed in H1 23 for a total consideration of
£202m, with total annualised revenues of £79m in the year
prior to purchase
|
|
|
–
|
Very
strong pipeline of high-quality M&A in place. Guidance on
targeted spend in FY 23 raised by £50m to
c.£300m
|
|
●
|
Declared interim dividend up 14.6% at 2.75p per share, in
line with our progressive policy
|
|
|
|
|
|
Andy Ransom, Chief Executive of Rentokil Initial plc,
said:
“Rentokil Initial has delivered a strong overall first half
performance. Our results show sustained trading momentum, with
organic growth of 5.9%. The Group enjoyed growth in every region
and continued to benefit from effective pricing to manage
inflationary costs. Revenue growth was further supported by another
excellent period of M&A with 24 high-quality businesses
acquired for a total consideration of £202m. I am especially
pleased with our progress in integrating Terminix. We are seeing
clear evidence of density benefits with the start of the pilot
programme and we remain firmly on track to deliver synergies. We
start the second half of the year with continued confidence in our
plans, both operational and strategic.”
2023 Outlook
Rentokil
Initial has a clear strategy to deliver growth and margin
expansion. Alongside the delivery of the Terminix integration, we
expect continued good underlying trading in the remainder of the
year, underpinned by our resilient business model and supportive,
structural growth drivers. Despite the continuing evolution of our
US Pest business, we expect to deliver H2 23 Organic Revenue growth
in North America broadly in line with our H1
performance.
Executing
on our disciplined integration plan, we remain firmly on course to
capture the benefits of the Terminix deal, including both our FY 23
pre-tax net cost synergy guidance of $60m year over year and total
annual pre-tax net cost synergies of at least $200m by the end of
FY 25.
We also
remain confident in our strong margin discipline. The majority of
headwinds to Hygiene & Wellbeing’s margin performance are
limited to H1, and we therefore expect the category’s
Adjusted Operating Margin in H2 to be in excess of 19.0%. Overall,
with effective margin protection from proactive cost inflation
management and margin accretion from strategy execution and synergy
delivery, we reiterate our current year guidance to grow Group
Adjusted Operating Margin to c.16.5% and North America Adjusted
Operating Margin to c.19.5%.
The
recent strengthening of GBP against USD leads to a revision in our
FX guidance from a tailwind in FY 23 of £15m-£25m to a
headwind of £15m-£20m.
Notwithstanding
enduring inflationary pressures, we remain confident in achieving
the operational and financial progress in FY 23 that we have
previously signposted. Furthermore, in view of our successful
deleveraging, net debt to EBITDA is anticipated to be approximately
3x by the end of FY 23, one year ahead of schedule.
Enquiries:
|
Investors / Analysts:
|
Peter
Russell
|
Rentokil
Initial plc
|
+44
(0)7795 166506
|
|
Media:
|
Malcolm
Padley
|
Rentokil
Initial plc
|
+44
(0)7788 978199
|
A
presentation for investors and analysts will be held today, 27 July
at 9.15am at Goldman Sachs, 25 Shoe Lane, London EC4 4AU. To
register attendance please email investor@rentokil-initial.com. The
event will also be available via a live audio webcast. Dial-in
details will be provided on the Company’s IR website
(https://www.rentokil-initial.com/investors.aspx). A recording will
be made available following the conclusion of the
presentation.
Notes
1 Non GAAP Measures – Organic Revenue (including and
excluding disinfection) growth represents the growth in Revenue
excluding the effect of businesses acquired during the year.
Acquired businesses are included in organic measures in the year
following acquisition, and the comparative period is adjusted to
include an estimated full year performance for growth calculations
(pro forma revenue). The Terminix acquisition is treated
differently to other acquisitions for Organic Revenue growth
purposes. The full pre-acquisition results of the Terminix business
are included for the comparative period and Organic Revenue growth
is calculated as the growth in Revenue compared to the comparative
period. This differing treatment for Terminix will expire at the
end of 2023 when we will have full year Terminix comparatives.
Organic Growth has no equivalent GAAP measure, and is presented to
help understand the element of revenue growth that does not relate
to acquisition activity.
This statement presents certain further non-GAAP measures, which
should not be viewed in isolation as alternatives to the equivalent
IFRS measure, rather they should be viewed as complements to, and
read in conjunction with, the equivalent IFRS measure. These
include revenue and profit measures presented at actual exchange
rates (“AER” – GAAP) and constant full year 2022
exchange rates (“CER” – Non-GAAP). Non-GAAP
measures include Adjusted Operating Profit, Adjusted Profit Before
Tax, Adjusted Profit After Tax, Adjusted EBITDA, Adjusted Interest,
Free Cash Flow, Adjusted Free Cash Flow, Adjusted Cash Flow
(previously named Operating Cash Flow), and Diluted Adjusted
Earnings Per Share. Adjusted Operating Profit and Adjusted Profit
Before Tax exclude certain items that could distort the underlying
trading performance. These measures may not be calculated in the
same way as similarly named measures reported by other companies.
Management believes that these measures provide valuable additional
information for users of Rentokil Initial’s Financial
Statements in order to better understand the underlying trading
performance in the year from activities and businesses that will
contribute to future performance. Adjusted Operating Profit
represents the performance of the continuing operations of the
Group (including acquisitions) and enables the users of the
accounts to focus on the performance of the businesses retained by
the Group, and that will therefore contribute to the future
performance. The Group’s internal strategic planning process
is also based on these measures, and they are used for incentive
purposes. Revenue and Adjusted Operating Profit are presented at
CER unless otherwise stated. An explanation of the measures used
along with reconciliation to the nearest IFRS measures is provided
in Notes 4,5 and 12.
2 Includes net synergy benefit but excludes costs to achieve which
are one-off by nature.
Summary of financial performance (at
CER)
Regional
Performance
|
|
Revenue
|
|
Adjusted Operating Profit
|
||||
|
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
|
|
North America
|
1,646
|
724
|
127.3%
|
|
304
|
117
|
163.2%
|
|
Pest
Control
|
1,601
|
679
|
135.6%
|
|
300
|
111
|
173.8%
|
|
Hygiene
& Wellbeing
|
45
|
45
|
0.4%
|
|
4
|
6
|
(29.9%)
|
|
|
|
|
|
|
|
|
|
|
Europe (inc. LATAM)
|
522
|
440
|
18.7%
|
|
95
|
84
|
12.4%
|
|
Pest
Control
|
250
|
192
|
30.0%
|
|
56
|
46
|
21.3%
|
|
Hygiene
& Wellbeing
|
166
|
157
|
6.2%
|
|
21
|
25
|
(15.1%)
|
|
France
Workwear
|
106
|
91
|
16.3%
|
|
18
|
13
|
34.1%
|
|
|
|
|
|
|
|
|
|
|
UK & Sub Saharan Africa
|
192
|
179
|
6.7%
|
|
46
|
46
|
(1.1%)
|
|
Pest
Control
|
98
|
88
|
10.4%
|
|
26
|
21
|
20.1%
|
|
Hygiene
& Wellbeing
|
94
|
91
|
3.2%
|
|
20
|
25
|
(19.6%)
|
|
|
|
|
|
|
|
|
|
|
Asia & MENAT
|
173
|
155
|
11.9%
|
|
24
|
22
|
6.4%
|
|
Pest
Control
|
128
|
109
|
17.4%
|
|
18
|
16
|
11.2%
|
|
Hygiene
& Wellbeing
|
45
|
46
|
(1.2%)
|
|
6
|
6
|
(6.6%)
|
|
|
|
|
|
|
|
|
|
|
Pacific
|
128
|
110
|
16.5%
|
|
29
|
24
|
22.3%
|
|
Pest
Control
|
64
|
49
|
30.4%
|
|
12
|
8
|
56.4%
|
|
Hygiene
& Wellbeing
|
64
|
61
|
5.2%
|
|
17
|
16
|
6.1%
|
|
|
|
|
|
|
|
|
|
|
Central
|
5
|
5
|
(2.1%)
|
|
(58)
|
(49)
|
(19.3%)
|
|
Restructuring costs
|
–
|
–
|
–
|
|
(6)
|
(5)
|
(24.7%)
|
|
Total at CER
|
2,666
|
1,613
|
65.3%
|
|
434
|
239
|
81.7%
|
|
Total at AER
|
2,671
|
1,572
|
69.9%
|
|
437
|
233
|
88.0%
|
Business Category
Performance
|
|
Revenue
|
|
Adjusted Operating Profit
|
||||
|
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
H1 2023
£m
|
H1
2022
£m
|
Change
%
|
|
|
Pest
Control
|
2,141
|
1,117
|
91.5%
|
|
412
|
202
|
105.1%
|
|
Hygiene
& Wellbeing
|
414
|
400
|
3.8%
|
|
68
|
78
|
(12.6%)
|
|
France
Workwear
|
106
|
91
|
16.3%
|
|
18
|
13
|
34.1%
|
|
Central
|
5
|
5
|
(2.1%)
|
|
(58)
|
(49)
|
(19.3%)
|
|
Restructuring
costs
|
–
|
–
|
–
|
|
(6)
|
(5)
|
(24.7%)
|
|
Total at CER
|
2,666
|
1,613
|
65.3%
|
|
434
|
239
|
81.7%
|
|
Total at AER
|
2,671
|
1,572
|
69.9%
|
|
437
|
233
|
88.0%
|
Note: Hygiene & Wellbeing performance partly reflects the
anticipated decrease in COVID disinfection revenues from
£14.2m in H1 22 to £1.6m in H1 23.
Group Overview
In order to help understand the underlying trading performance,
unless otherwise stated, the figures below are presented at
constant exchanges rates and Organic Revenue growth figures exclude
the COVID disinfection business.
Revenue
The
Group delivered strong topline momentum in H1, with Revenue rising
65.3% to £2,666m and Organic Revenue up 5.9%, ahead of
medium-term Organic Revenue guidance. Statutory Revenue was up
69.9% to £2,671m at AER. Revenue growth in North America was
up 127.3%, benefiting from the Terminix acquisition. Europe (inc.
LATAM), the Group’s second largest region, was up strongly by
18.7%. Revenue in the Pacific region increased by 16.5% while Asia
& MENAT was up 11.9% and the UK & Sub Saharan Africa was up
6.7%. Group Organic Revenue growth including COVID disinfection was
5.4%. As expected, COVID disinfection revenue in H1 reduced
significantly to £1.6m (H1 22: £14.2m)
Our
Pest Control category grew Revenue by 91.5% (5.6% Organic) to
£2,141m, underpinned by strong price progression and good
customer retention, albeit impacted by softer US Pest Control
services due to lower industry-wide lead flow from residential and
termite customers. Hygiene & Wellbeing Revenue increased by
3.8% (5.2% Organic) to £414m. This was supported by resilient
demand for washroom services, offset by the anticipated reduction
in COVID disinfection and related services, and the non-repeat of
UK COVID credit note releases. Robust market demand was reflected
in the continued strong contribution from our France Workwear
business with Revenue up by 16.3% to £106m (16.3%
Organic).
Profit
Adjusted
Operating Profit rose by 81.7% during the first six months to
£434m, reflecting the benefit of topline growth across all
major regions and categories, in addition to the contribution from
the Terminix transaction. Adjusted PBT at AER increased 67.3%,
despite a £6m FX headwind. Group Adjusted Operating Margin
increased year on year by a total of 150bps to 16.3%. Adjusted
Operating Margin for Pest Control increased 130bps to 19.2%. There
was a net benefit of 110bps to Group margin from the delivery on
Terminix synergies, partially offset by short-term margin dilution
from increased bolt-on M&A activity, predominantly in Europe.
Hygiene & Wellbeing Adjusted Operating Margin decreased 310bps
to 16.5% impacted by the anticipated reduction in COVID
disinfection and related services, the non-repeat of UK COVID
credit note releases, and the transfer of Ambius management from
North America Pest Control.
We have
continued to deliver on our strategy of driving density
improvements including through M&A integration to create
long-term efficiencies. Price increases have also been successfully
implemented over the course of the half year. The extent to which
the Group has been able to offset inflationary pressures
demonstrates the resilience of the business model and the essential
nature of our core products and services.
Restructuring
costs excluding Terminix of £6m (at CER and AER) were up
£1m on the prior year (H1 22: £5m at CER and AER),
consisting mainly of costs in respect of initiatives focused on our
ongoing North America transformation programme. The Company reports
these restructuring costs within Adjusted Operating Profit.
Adjusted profit before tax (at AER) of £377m, which excludes
one-off and adjusting items and amortisation costs, increased by
67.3%. Adjusted interest of £67m at actual exchange rates was
higher year on year by £55m, driven by £57m of higher
interest costs from Terminix related financing, partially offset by
a £2m higher impact from hyperinflation accounting. One-off
and adjusting items (operating) at AER of £46m includes
£35m of Terminix integration costs and £8m of other
M&A and integration costs. Statutory profit before tax at AER
was £240m, an increase of 48.1% on the prior year (H1 22:
£162m).
Cash
(at AER)
Adjusted
Cash Flow of £401m was up from £202m in H1 22. Higher
trading profits resulted from organic and acquisitive growth.
Adjusted EBITDA was £602m, up 72.0% from £350m. One-off
and adjusting items totalled £78m, reflecting P&L items of
£46m and a net c.£32m movement in one-off accruals since
December 2022, as presented at the Preliminary Results. The Group
had a £26m working capital outflow in the first six months of
the year.
Capital
expenditure of £102m was incurred in the period (H1 22:
£83m), reflecting the inclusion of Terminix capital
expenditure. Lease payments were up 80.0% to
£81m.
Cash
interest payments of £114m were £95m higher than in the
prior year, reflecting the payment in arrears of coupon interest on
bonds issued in 2022 in relation to the Terminix transaction. Cash
tax payments for the period were £58m, an increase of
£26m compared with the corresponding period last year, largely
related to the inclusion of Terminix trading results. Free Cash
Flow was £229m (H1 22: £151m), with Adjusted Free Cash
Flow Conversion of 83.0% due to the timing of interest
payments.
Update on the Terminix Integration Process
The
Terminix transaction adds valuable scale and capabilities and we
have been focused on delivering the deal’s significant
benefits. We are in the first year of a three year integration
programme, yet strong progress has already been made. The delivery
of synergies is firmly on track, and we continue to expect $60m
incremental pre-tax net P&L cost synergies in FY 23 and total
synergies of at least $200m in FY 25.
As
anticipated, the large majority of gross cost synergies in the
current year are being delivered by Selling, General and
Administrative (SG&A) initiatives, in particular in regard to
procurement and support functions:
|
●
|
Procurement
activity is setting the early pace for the overall integration and
has quickly demonstrated the value of the combined company.
Procurement is anticipated to deliver most of its synergies by the
end of FY 23 and is tracking to plan. In H1 23 we have leveraged
our enhanced buying power to help optimise spending on both
products for our frontline colleagues and on products and services
to support the business. Fleet policies have been aligned and a
single fleet supplier has been appointed for North America. A
material benefit in insurance procurement was also achieved in the
period.
|
|
●
|
Significant
progress has been made to right-size the new organisation to
deliver world-class support to our frontline colleagues at a
competitive cost base. Alongside the retention of critical talent,
the removal of duplication in central functions through
restructuring in headcount and other associated G&A costs has
been substantially advanced.
|
In FY
23, we expect $12m of gross cost synergies from field operations
(of the total $125m recurring gross cost synergies from field
operations by FY 25). In H1, 44 branch locations were exited as
part of the consolidation of the legacy network and co-location of
colleagues. This brings the total number of branch locations exited
since closing the deal to 64, and, by the end of H2 we would expect
this to exceed 100. In addition to executing branch co-locations
that deliver early property synergies, the focus for most of the
current year is planning and preparation as we approach the more
complex task in 2024 of fully integrating Terminix and Rentokil
North America branches, consolidating routes and aligning the
customer offering.
This
year we expect to make approximately $30m of investment into the
business to enable the success of the integration. Important
planning and investment have been made in HR to underpin synergy
delivery and to ensure the quality of the enhanced operations going
forward. All functions and roles in the combined business have been
through an organisation design process. We have completed job
descriptions with pay and grading, and talent selection has been
finalised. The 3,500 role offers extended have been met with a 97%
acceptance rate. We have also concluded the harmonisation of
benefits and paid time off between legacy Terminix and Rentokil
North America positions. The design of harmonised pay plans is
expected to be finalised in the second half of the current
year.
IT
infrastructure is another important enabler of administrative and
operational efficiencies to be gained from the integration plan. As
part of our Best of Breed strategy we have now identified the most
appropriate IT solutions for functions and processes across the
combined organisation, from HR and Finance applications through to
service planning and service delivery platforms. These have been
selected principally from either Rentokil North America or
Terminix, but also externally where the ideal future state solution
was not already present. The chosen IT solutions will replace a
number of composite legacy systems. They are expected to deliver
improved overall performance and resilience, better enabling both
our employees and customers.
|
|
Year over Year P&L Impact
|
|||
|
|
|
2023
|
|
|
|
|
Achieved 2022
|
H1 Actuals
|
H2 Forecast
|
FY 2023
|
|
Selling, General and Admin Expenses:
Sales
productivity/Procurement/support functions
|
$15m
|
$40m
|
$38m
|
$78m
|
|
Field Operations:
Branch
Consolidation/Density Benefits/Productivity
|
–
|
$6m
|
$6m
|
$12m
|
|
Gross Synergies
|
$15m
|
$46m
|
$44m
|
$90m
|
|
Investments:
Salary
& Benefits HarmonizationSHE & Innovation
Centre/IT/Branding/Additional SOX/Audit and Listing
Fees
|
($2m)
|
($9m)
|
($21m)
|
($30m)
|
|
Net Synergies
|
$13m
|
$37m
|
$23m
|
$60m
|
Positive Results from Initial Integration Pilots
In H1
23 we began the first phase of our programme of pilot integrations,
undertaking two branch integrations within the Rentokil North
America legacy network. These covered locations that previously had
each generated revenues of c.$65m and c.$97m, and entailed the
consolidation of a total of 40 branches into 23 branches. Locations
had each been serviced by several different brands, service
protocols, operating systems and pay plans. Our approach in these
market pilots showed that the migration, while demanding, was
successful and we are seeing clear evidence of density benefits.
The combination of larger branches with higher network density
drove an approximately 5 percentage point margin expansion in the
pilot areas. We will continue to monitor the pilots for any impact
on organic growth.
As
previously stated, we anticipate that our average annual branch
revenue post-integration will increase to approximately $8m to
$10m. We have recently conducted a detailed analysis of our North
America branch network that shows a clear link between branch size
and margin, such that branches with annual revenue of more than $8m
deliver Adjusted Operating Profit margin that is about 10% higher
than branches with revenue of less than $3m. Across our network of
600+ branches, we currently have 100+ branches operating at more
than $8m annual revenue and around 200+ operating at less than $3m
annual revenue.
Looking
forward to the remainder of 2023, we will pilot test projects in
relation to HR information systems and a single pay plan, data
migration and data mapping, and technology applications. Our pilot
programme provides a platform to test our implementation approach,
manage risk and prove value. Contingent on the evaluation outcome
of the pilot programme, the branch integration phase will be
deployed at scale across North America beginning January
2024.
The
integration of the two businesses is a large, complex programme
with many interrelated parts. We are taking a disciplined and
measured approach, with rigorous project governance and risk
management procedures in place. We have set clear expectations and
goals throughout the business, and this is already helping to
deliver results.
We
remain confident in the value creation opportunity of the Terminix
acquisition and integration. These initiatives – and the key
enablers that underpin our strategy – will allow us to build
the organisational capability to deliver our ambition of organic
growth of 1.5x the North America industry rate, post
integration.
Regional performance
review
Due to the international nature of the Group, foreign exchange
movements can have a significant impact on regional performance.
Unless otherwise stated, percentage movements in Revenue and
Adjusted Operating Profit are presented at constant exchange
rates.
North America
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
1,646
|
127.3%
|
4.1%
|
4.1%
|
1,654
|
138.4%
|
|
Disinfection
|
–
|
-80.5%
|
|
|
–
|
-79.7%
|
|
Adjusted
Operating Profit
|
304
|
163.2%
|
|
|
306
|
176.0%
|
|
Adjusted
Operating Margin
|
18.5%
|
2.5%
|
|
|
18.5%
|
2.5%
|
|
Operating
Profit
|
209
|
138.7%
|
|
|
210
|
150.3%
|
Alongside
the Terminix integration process, the North America business has
driven sustained trading momentum. In the first six months of the
year, Revenue was up 127.3%, benefiting from the Terminix
acquisition. Organic Revenue grew 4.1%, achieved despite the
planned exit of 64 branches since October 2022 as part of the
integration process. The business delivered Organic Revenue growth
of 4.2% in North America Pest Control and 4.8% in North America
Pest Control services for our commercial, residential, and termite
customers. Q2 Organic Revenue growth of 4.0% for Pest Control
services was impacted by lower inbound lead flow for residential
and termite services, which mirrored trends observed in digital
search demand for the Pest Control industry as whole. General
search demand for pest control and termite terms was down year on
year, while search for commercial, mosquito and bed bugs has shown
more resilience. We have remained disciplined in our marketing
spend, with a focus on lead quality over quantity. The revenue
generated per lead has increased substantially with this strategy,
leading to a higher quality mix and positively impacting margins.
Growth in the products distribution business was impacted from
customer destocking due to high inventory levels. However,
underlying demand in products distribution bounced back toward the
end of H1 and is expected to return to historic levels in
H2.
Our
planned cessation of Terminix’s door to door selling
programme in Canada, as well as the anticipated impacts of our
early branch integration pilots across 40 branches, together
contributed to a temporary reduction of organic growth in North
America in the half year of an estimated 32 basis points. We are
very pleased with our learnings from the pilots, which will inform
the implementation of additional pilots planned for the next few
months, ahead of the commencement of our full branch integration
programme planned for 2024.
Adjusted
Operating Profit growth of 163.2% in North America reflects the
combined impact from higher revenues and the Terminix acquisition.
Strong price realisation has continued to successfully offset
expected inflationary pressures. We closely monitor labour, fuel
and direct cost inflation to adjust our pricing strategy on a
regular basis. Adjusted Operating Margins in North America were up
250bps year on year to 18.5%. There was a net benefit of 190bps
from the delivery on Terminix synergies.
In the
Terminix termite business, we have continued to see a number of
improved year on year trends in H1, including a 12% reduction in
total filed warranty claims and a 24% reduction in open warranty
claims. Total filed warranty claims in the Mobile Bay area
decreased by 51%. These data points support provisions for termite
claims at the half year being in line with previous
expectations.
Total
North America colleague retention, including Terminix, increased to
72.4% (FY 22: 70.1%). Terminix colleague retention has seen
continued improvement, up to 67.7% (FY 22: 63.8%), with particular
progress in technician roles. Terminix has seen an increase of 5.3
percentage points in colleague retention since the close of the
deal in October 2022. The Group continued to make investments in
being an Employer of Choice. We are seeing ongoing success with our
recruiting initiatives, with time-to-fill rates decreasing over the
half year. Despite price increases, total customer retention in
North America increased to 83.5% (FY 22: 83.3%).
Notwithstanding
the considerable focus required for the Terminix integration, our
North American bolt-on M&A programme continued apace, with the
purchase of 6 businesses with combined annualised revenues of
£37m in the year prior to purchase. As we integrate Terminix,
we continue to selectively pursue high quality M&A assets in
the North America region.
Europe (incl. LATAM)
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
522
|
18.7%
|
11.1%
|
9.8%
|
529
|
22.0%
|
|
Disinfection
|
1
|
-88.2%
|
|
|
1
|
-87.2%
|
|
Adjusted
Operating Profit
|
95
|
12.4%
|
|
|
97
|
16.8%
|
|
Adjusted
Operating Margin
|
18.2%
|
-1.0%
|
|
|
18.4%
|
-0.9%
|
|
Operating
Profit
|
75
|
-0.2%
|
|
|
80
|
8.2%
|
The
region enjoyed another period of strong revenue performance, with
Revenue up by 18.7% in the first six months of the year to
£522m. The business delivered double-digit Organic Revenue
growth of 11.1%, driven by both effective price increases and
resilience in overall demand. Revenue growth in Pest Control was
30.0%, with a strong contribution from larger markets like France
and Benelux. Hygiene & Wellbeing grew Revenue by 6.2% in the
period driven by continued momentum in the core washrooms business.
In premises and enhanced environments, Ambius sustained a good
performance, partially offset by Specialist Hygiene and Dental,
which both continue to experience some post-COVID disruption.
Strong demand has continued to drive a supportive market for France
Workwear, which delivered Revenue growth of 16.3%. Adjusted
Operating Profit in the region grew by 12.4% to £95m. Adjusted
Operating Margin reduced by 100bps to 18.2%, impacted by short-term
margin dilution from increased M&A activity, predominantly
acquisitions in Sweden (Terminix) and Israel (Eitan Amichai IPM).
The movement also reflects a reduction in COVID disinfection
business. These factors, the impact of which will fall away in H2,
were partly offset by the strong performance in France
Workwear.
Customer
retention has remained strong at 88.3% (FY 22: 88.5%.) While labour
markets throughout the region remain tight, colleague retention
rates have remained relatively stable across the region at 89.4%
(FY 22: 89.1%), with both service and sales colleagues trending
well.
M&A
continued strongly in Europe and Latin America. 8 business
acquisitions were completed in total with annualised revenues of
£7m in the year prior to purchase.
UK & Sub-Saharan Africa
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
192
|
6.7%
|
3.9%
|
3.9%
|
190
|
6.0%
|
|
Disinfection
|
–
|
-100.0%
|
|
|
–
|
-100.0%
|
|
Adjusted
Operating Profit
|
46
|
-1.1%
|
|
|
46
|
-1.7%
|
|
Adjusted
Operating Margin
|
23.8%
|
-1.9%
|
|
|
23.9%
|
-1.8%
|
|
Operating
Profit
|
41
|
-3.5%
|
|
|
40
|
-4.2%
|
The
region delivered a resilient trading performance against a
challenging macro backdrop and strong prior year comparators.
Overall, Revenue for UK & Sub-Saharan Africa increased by 6.7%
to £192m with a positive contribution from both business
categories, Pest Control and Hygiene & Wellbeing. Organic
Revenue growth was up 3.9%. The Pest Control business grew strongly
with Revenue up 10.4% to £98m. Hygiene & Wellbeing revenue
increased 3.2% to £94m, despite lapping COVID boosted
comparators in the medical waste business from the same period last
year.
Adjusted
Operating Profit was down 1.1% to £46m with Adjusted Operating
Margin reduced by 190bps to 23.8%. The Pest Control category
sustained strong margins. However, the region’s margin
performance was dampened by the anticipated reduction in COVID
disinfection and related services, and the non-repeat of UK COVID
credit note releases. The impact of these factors will fall away in
H2. The region continued to face well publicised inflationary
headwinds. However, significant cost increases have been well
managed by our long-established pricing and margin management
systems, process and controls.
Price
increases have been delivered alongside a customer retention rate
that has slightly improved to 86.7% (FY 22: 86.6%). Owing to
sustained investment in our people and training programmes as well
as some recent loosening of the UK labour market, colleague
retention strengthened to 83.7% for the first six months (FY 22:
77.9%).
The
region acquired 1 business in the Hygiene & Wellbeing category
with annualised revenues in the year prior to purchase of
£17m. This acquisition was of the company Urban Planters, a
leading UK service provider of planting schemes for business
premises.
Asia & MENAT
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
173
|
11.9%
|
11.3%
|
6.5%
|
168
|
10.9%
|
|
Disinfection
|
1
|
-89.8%
|
|
|
1
|
-89.8%
|
|
Adjusted
Operating Profit
|
24
|
6.4%
|
|
|
23
|
8.0%
|
|
Adjusted
Operating Margin
|
13.4%
|
-0.7%
|
|
|
13.7%
|
-0.4%
|
|
Operating
Profit
|
17
|
1.5%
|
|
|
17
|
3.6%
|
Asia
& MENAT delivered another strong performance in the first six
months of 2023. Revenue rose by 11.9%, of which 11.3% was Organic,
underpinned by contractual activity. The positive performance was
led by the Pest Control business and the region’s largest
markets, including Indonesia, Malaysia and Singapore. While Hong
Kong continued to be challenged by a subdued economic environment,
there was slightly improved trading in China.
Adjusted
Operating Profit in the region increased 6.4% to £24m and
Adjusted Operating Margin was down slightly by 70bps to 13.4%. The
period lapped stronger COVID disinfection revenues with the
headwind set to materially reduce in the second half of the current
year. Customer retention was 80.6% (FY 22: 81.3%). Regional
operations have benefited from an improved, high colleague
retention rate of 89.3% (FY 22: 86.1%), while the average time to
fill vacancies has remained steady year on year.
Asia
acquired 4 businesses in the year with annualised revenues in the
year prior to purchase of £6m.
Pacific
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
128
|
16.5%
|
7.4%
|
7.3%
|
125
|
14.8%
|
|
Disinfection
|
–
|
-100.0%
|
|
|
–
|
-100.0%
|
|
Adjusted
Operating Profit
|
29
|
22.3%
|
|
|
29
|
20.6%
|
|
Adjusted
Operating Margin
|
22.9%
|
1.1%
|
|
|
22.9%
|
1.1%
|
|
Operating
Profit
|
26
|
18.7%
|
|
|
25
|
17.1%
|
The
Pacific region delivered an excellent first half performance.
Revenue accelerated by 16.5% to £128m. Organic Revenue grew
7.4% as pricing was complemented with volume growth. Pest Control
delivered 30.4% Revenue growth, with notable strength in commercial
services. Good sales and customer retention were also evident in
the Hygiene & Wellbeing business, where Revenue growth was
5.2%. The region saw good demand for Ambius services.
Adjusted
Operating Profit in the Pacific grew strongly by 22.3% to £29m
and Adjusted Operating Margins rose by 110bps to 22.9%, supported
by effective mitigation of cost inflation. The customer retention
rate remained in the high 80s at 88.1% (FY 22: 88.8%). Colleague
retention in the region has improved to 75.3% (FY 22: 72.9%),
despite continued tight labour markets.
The
region acquired 5 businesses, with 3 in Australia and 2 in New
Zealand. These acquisitions had total annualised revenues in the
year prior to purchase of £12m.
Category performance review
Pest Control
|
|
H1 23
CER£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
2,141
|
91.5%
|
5.6%
|
5.6%
|
2,144
|
97.7%
|
|
Adjusted
Operating Profit
|
412
|
105.1%
|
|
|
415
|
112.3%
|
|
Adjusted
Operating Margin
|
19.2%
|
1.3%
|
|
|
19.3%
|
1.3%
|
|
Operating
Profit
|
317
|
100.5%
|
|
|
322
|
109.4%
|
Our
Pest Control business, now including Terminix, is the largest
operator in both the US, the world’s biggest pest control
market, and the world overall. Rentokil Initial is a leading global
player in a resilient and non-cyclical industry characterised by
positive and strong long-term structural growth drivers. We have
strengthened our position through organic growth and by
establishing stronger market positions, through the introduction of
innovative products and services, acquisitions to build scale and
density, and our determination to be an Employer of Choice across
our global operations.
Our
Pest Control business delivered strong growth in the first half of
the year, underpinned by the critical nature of our services.
Revenue was up by 91.5% to £2,141m, benefiting from Organic
Revenue growth of 5.6% and M&A, including the Terminix
transaction.
Overall
performance has been supported by both pricing and volumes, led by
the Commercial Pest Control business, which has a high proportion
of contractual activity and benefited from continued good customer
retention rates. North America Organic Revenue growth was 4.2%,
achieved alongside the integration pilot programme and despite
lower industry-wide lead flow from residential and termite
customers. Revenue in growth markets, representing 91% of the Pest
Control business, was up 100.8%, while revenue in emerging markets
was up 28.1%. Adjusted Operating Profit was up by 105.1% to
£412m and Adjusted Operating Margin increased 130bps to 19.2%.
There was an uplift to the resilient underlying margin performance
from Terminix synergies of 140bps, partly offset by short-term
margin dilution from increased M&A activity, predominantly in
Europe. For H1 23, Pest Control represented 80.4% of Group Revenue
and 82.7% of Group Adjusted Operating Profit (excluding central and
restructuring costs). M&A has continued to be strong this year,
and we have acquired 19 pest control businesses in the period with
annualised revenues in the year prior to acquisition of
£54m.
Hygiene & Wellbeing
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
414
|
3.8%
|
5.2%
|
1.8%
|
414
|
5.4%
|
|
Disinfection
|
2
|
-88.4%
|
|
|
2
|
-87.9%
|
|
Adjusted
Operating Profit
|
68
|
-12.6%
|
|
|
68
|
-11.9%
|
|
Adjusted
Operating Margin
|
16.5%
|
-3.1%
|
|
|
16.4%
|
-3.3%
|
|
Operating
Profit
|
65
|
-12.0%
|
|
|
64
|
-11.3%
|
Rentokil
Initial offers a wide range of hygiene and wellbeing services.
Inside the washroom we provide hand hygiene (soaps and driers), air
care, in-cubicle (feminine hygiene units), no-touch products and
digital hygiene services. In addition to core washroom hygiene, we
deliver specialist hygiene services such as clinical waste
management. We’re also improving the customer experience
through premium scenting, plants, air quality monitoring and green
walls. Customer sectors range from public sector (schools,
government buildings) and facilities management through to hotels,
bars and restaurants, industrials and retail.
Hygiene
& Wellbeing Revenue increased by 3.8% to £414m. This was
supported by resilient demand for washroom services, offset by the
anticipated reduction in COVID disinfection and related services,
and the non-repeat of UK COVID credit note releases. COVID
disinfection revenues decreased from £14.2m in H1 22 to
£1.6m in H1 23. Organic Revenue growth in the category was
5.2%. Organic Revenue growth in core washrooms was 6.1%, while
Organic Revenue growth in premises and enhanced environments was
3.5%. Adjusted Operating Profit was down by 12.6% to £68m and
Adjusted Operating Margin decreased 310bps to 16.5%. Hygiene &
Wellbeing margin was impacted by the anticipated reduction in COVID
disinfection and related services, the non-repeat of UK COVID
credit note releases, and the transfer of Ambius management from
North America Pest Control. The H2 impact of these headwinds to
Hygiene & Wellbeing margin is expected to be c.100bps or
one-third of the H1 impact. They are anticipated to be offset by
underlying operational improvements, with H2 margin expected to be
in excess of 19.0%.
We have
acquired 5 hygiene businesses in the first six months with
annualised revenues of c.£24m in the year prior to
purchase.
France Workwear
|
|
H1 23
CER
£m
|
CER
Growth
|
Organic
Growth excl
Disinfection
|
Organic
Growth incl
Disinfection
|
H1 23
AER
£m
|
AER
Growth
|
|
Revenue
|
106
|
16.3%
|
16.3%
|
16.3%
|
108
|
20.6%
|
|
Adjusted
Operating Profit
|
18
|
34.1%
|
|
|
18
|
39.1%
|
|
Adjusted
Operating Margin
|
16.9%
|
2.2%
|
|
|
16.9%
|
2.2%
|
|
Operating
Profit
|
18
|
34.9%
|
|
|
18
|
39.8%
|
Strong
demand has continued to drive a supportive market for France
Workwear, which delivered Revenue growth of 16.3% to £106m,
all of which was organic. Robust volumes have been aided by ongoing
market recovery in the hospitality sector in particular, and driven
by both strong new business sales and upselling. The
category’s performance has been supported by effective price
progression. Inflation was fully covered with successful price
increases, while our investment in plant and machinery has enabled
us to deliver more efficient and sustainable operations. In the
first six months of the year, Adjusted Operating Profit increased
by 34.1% to £18m, translating to a step up in Adjusted
Operating Margin of 220bps to 16.9%.
Continued excellent execution on
bolt-on M&A
Bolt-on
M&A activity continued at pace in the first half of the year.
The Group acquired 24 new businesses across both our growth and
emerging markets. An aggregate consideration of £202m was paid
for these acquired businesses with total annualised revenues of
£79m in the year prior to purchase. In North America, 6 new
businesses were added. This included the acquisition of RK
Environmental/Comprehensive Food Safety, a specialist in pest
management services and food safety audit consulting to the
commercial food industry operating in 31 US states. RK had
annualised revenues of c.£16m in the year prior to purchase,
ranking #44 on the Pest Control Technology 2022 Top 100 list. 5
acquisitions were made in both Europe and the Pacific. Building on
prior year success, 3 deals were made in Spain, creating the market
leader. In our emerging markets of Asia, MENAT and LATAM, 7 deals
were completed with total annualised revenues of £8m in the
year prior to purchase.
We will
continue to seek attractive bolt-on deals, both in Pest Control and
with an increased focus on Hygiene & Wellbeing, to build
density in existing markets, and pursue acquisitions in new markets
and the major Cities of the Future. Our pipeline of prospects
remains very strong and our guidance on spend on M&A for FY 23
is raised from c.£250m to c.£300m.
Employer of
Choice
Rentokil
Initial is committed to being a world-class Employer of Choice,
with colleague safety and the attraction, recruitment and retention
of the best people from the widest possible pool of talent being
key business objectives globally. As an organisation, we strongly
believe that creating a diverse and inclusive workforce that
reflects the business environment in which we operate will increase
colleague engagement and customer satisfaction, as well as drive
increased innovation, enhance our reputation and therefore boost
our financial performance.
The
global labour market remained tight through the course of the first
half of the year. Nevertheless, we are seeing good results from our
sustained investment in recruitment and training, with 6
consecutive months of improvement in colleague retention. Total
Group colleague retention, restated to include Terminix, was up 2.6
percentage points to 82.0% (FY 22: 79.5%). Terminix colleague
retention has seen ongoing improvement, up from 63.8% for FY 22 to
67.7%.
Innovation and
Technology
The
Company’s investment in innovation and technology continues
to drive profitable growth in the business. It strengthens our
brand and cements our leadership position, enabling us to provide
enhanced service to customers and target key growth sectors, while
lowering our operating costs and improving our sustainability
credentials.
In the
Pest Control category, technology-enabled innovations have been
especially important in helping to differentiate us from our
industry competitors. Rentokil has developed the world’s
leading digital pest control platform providing an unmatched level
of reporting and insight for our customers. In the first half of
the year, we rolled out an additional 29,000 units of our
award-winning PestConnect solution, which provides a real-time,
early warning digital system for monitoring and controlling
rodents. We now have 319,000 units in operation across 18,000
sites, and six countries where more than 10% of the commercial
portfolio benefits from connected devices. This includes the
Netherlands that is approaching 30% of the commercial portfolio.
The PestConnect product range has also been expanded with the
introduction of Radar X for businesses, which has successfully
completed customer trials and is set for market launch later this
year. This is our most sustainable connected device to date, using
carbon dioxide gas rather than rodenticides and benefiting from a
longer battery life and more recyclable parts.
In the
Hygiene & Wellbeing category, our product initiatives for both
the core washroom and enhanced environments are delivering
benefits. The global roll-out of our Luna Dry range has supported a
17% increase in hand dryer unit sales, which notably included an
airport contract in the Nordics for Luna units. In the period, we
installed another 120,000 hygiene units from our popular Signature
colour range. The Group sustained its focus on the high-growth air
care market, already with a product range that features air
purification, air sterilisation and air scenting products. In H1 23
there was a 10.9% year on year increase in the sale of new air care
dispensers, led by a 50% increase in dispensers for air scenting.
This was accompanied by the recent launch of our new premium
scenting product, the AQ890 freestanding tower that has 50
intensity levels to cater for peak business hours and traffic flow.
Led by the Asia region, we also secured our first truly global
premium scenting agreement with a premier hotel group across 21
countries.
North America Innovation Centre
In line
with our commitment made at the time of the Terminix transaction
announcement, the Group will be opening a new North American
Innovation Centre focused on residential, termite, vector control
and sustainable fumigation. Housing a combination of entomologists,
vector scientists, fumigation chemists and residential product
owners, the centre will conduct research aimed at providing
transformative solutions to pest control challenges, as well as
delivering training for frontline colleagues. As part of this
programme, we are pleased to have appointed Dr Cassie Krejci as
Head of Science & Innovation North America.
Financial review
Central and regional overheads
Central
and regional overheads of £58m (at CER and AER) were up
£9m on the prior year (H1 22: £49m at CER and £48m
at AER) driven by higher share based payment charges for the larger
combined organisation.
Restructuring costs
With
the exception of integration costs for significant acquisitions,
the Company reports restructuring costs within Adjusted Operating
Profit. Costs associated with significant acquisitions are reported
as one-off items and excluded from Adjusted Operating Profit.
Restructuring costs of £6m (at CER and AER) were up £1m
on the prior year (H1 22: £5m at CER and AER). They consisted
mainly of costs in respect of initiatives focused on our ongoing
North America transformation programme.
Interest (at AER)
Adjusted
interest of £67m at actual exchange rates was higher year on
year by £55m, driven by £57m of higher interest costs
from Terminix related financing, partially offset by £2m
higher impact from hyperinflation of £8m (H1 22: £6m).
Cash interest in H1 2023 was £114m (H1 22: £19m)
reflecting both higher interest on debt raised for the Terminix
acquisition and the phasing of coupon payments annually in
arrears.
In
Appendix 1 we have shown a summary P&L interest table
demonstrating how the components of our financing drive interest
costs and incomes and the expected range for 2023 at average
exchange rates. Changes in exchange rates during the balance of
2023 will also impact the reporting of interest costs for
2023.
Tax
The
income tax charge for the period at actual exchange rates was
£55m on the reported profit before tax of £240m, giving
an effective tax rate (ETR) of 22.9% (H1 22: 23.2%). The
Group’s ETR before amortisation of intangible assets
(excluding computer software), one-off and adjusting items and the
net interest adjustments for H1 23 was 23.4% (H1 22: 21.8%). This
compares with a blended rate of tax for the countries in which the
Group operates of 25% (H1 22: 24%).
Net debt and cash flow
|
£m
at actual exchange rates
|
Year to
Date
|
||
|
H1 2023
£m
|
H1
2022
£m
|
Change
£m
|
|
|
Adjusted
Operating Profit
|
437
|
233
|
204
|
|
Depreciation
|
147
|
114
|
33
|
|
Other
|
18
|
3
|
15
|
|
Adjusted
EBITDA
|
602
|
350
|
252
|
|
One-off
and adjusting items in working capital
|
32
|
(8)
|
40
|
|
Working
capital
|
(26)
|
(16)
|
(10)
|
|
Movement
on provisions
|
(26)
|
1
|
(27)
|
|
Capex
– additions
|
(102)
|
(83)
|
(19)
|
|
Capex
– disposals
|
2
|
3
|
(1)
|
|
Capital
element of lease payments and initial direct costs
incurred
|
(81)
|
(45)
|
(36)
|
|
Adjusted
Cash Flow
|
401
|
202
|
199
|
|
Interest
|
(114)
|
(19)
|
(95)
|
|
Tax
|
(58)
|
(32)
|
(26)
|
|
Free
Cash Flow
|
229
|
151
|
78
|
|
Acquisitions
|
(175)
|
(127)
|
(48)
|
|
Dividends
|
(131)
|
(80)
|
(51)
|
|
Cost of
issuing new shares
|
–
|
(13)
|
13
|
|
Cash
impact of one-off and adjusting items
|
(78)
|
(15)
|
(63)
|
|
Other
|
(1)
|
–
|
(1)
|
|
Debt
related cash flows
|
|
|
|
|
Cash
outflow on settlement of debt related foreign exchange forward
contracts
|
(3)
|
1
|
(4)
|
|
Net
investment in term deposits
|
–
|
(2)
|
2
|
|
Proceeds
from new debt
|
–
|
1,744
|
(1,744)
|
|
Debt
repayments
|
–
|
(136)
|
136
|
|
Debt
related cash flows
|
(3)
|
1,607
|
(1,610)
|
|
|
|
|
|
|
Net
(decrease)/increase in cash and cash equivalents
|
(159)
|
1,523
|
(1,682)
|
|
Cash
and cash equivalents at the beginning of the period
|
879
|
242
|
637
|
|
Exchange
losses on cash and cash equivalents
|
(22)
|
23
|
(45)
|
|
Cash
and cash equivalents at end of the financial period
|
698
|
1,788
|
(1,090)
|
|
|
|
|
|
|
Net
(decrease)/increase in cash and cash equivalents
|
(159)
|
1,523
|
(1,682)
|
|
Debt
related cash flows
|
3
|
(1,607)
|
1,610
|
|
IFRS 16
liability movement
|
(7)
|
1
|
(8)
|
|
Debt
acquired
|
18
|
(1)
|
19
|
|
Bond
interest accrual
|
35
|
–
|
35
|
|
Foreign
exchange translation and other items
|
136
|
(77)
|
213
|
|
Decrease/(increase)
in net debt
|
26
|
(161)
|
187
|
|
Opening
net debt
|
(3,296)
|
(1,285)
|
(2,011)
|
|
Closing
net debt
|
(3,270)
|
(1,446)
|
(1,824)
|
Adjusted
Cash Flow of £401m was up from £202m in H1 22. Higher
trading profits resulted from organic and acquisitive growth.
Adjusted EBITDA was £602m, up 72.0% from £350m. One-off
and adjusting items totalled £78m, reflecting P&L items of
£46m and a net c.£32m movement in one-off accruals since
December 2022, as presented at the Preliminary Results. The Group
had a £26m working capital outflow in the first six months of
the year.
Capital
expenditure of £102m was incurred in the period (H1 22:
£83m), reflecting the inclusion of Terminix capital
expenditure. Lease payments were up 80.0% to
£81m.
Cash
interest payments of £114m were £95m higher than in the
prior year, reflecting the payment in arrears of coupon interest on
bonds issued in 2022 in relation to the Terminix transaction. Cash
tax payments for the period were £58m, an increase of
£26m compared with the corresponding period last year, largely
related to the inclusion of Terminix trading results. Free Cash
Flow was £229m (H1 22: £151m), with Adjusted Free Cash
Flow Conversion of 83.0% due to the timing of interest
payments.
Cash
spend in H1 on current and prior year acquisitions was £175m,
dividend payments were £131m and the cash impact of one-off
and adjusting items was £78m (largely related to the Terminix
acquisition). Foreign exchange translation and other items of
£136m is primarily due to the weakening of the Dollar against
Sterling. Overall, this led to a change in net debt of £26m
and closing net debt of £3,270m.
Going Concern
The
Board continues to adopt the going concern basis in preparing the
accounts on the basis that the Group’s strong liquidity
position and its demonstrated ability to manage the level of
capital expenditure, dividends or expenditure on bolt-on
acquisitions are sufficient to meet the Group’s forecast
funding needs, including those modelled in a severe but plausible
downside case.
Funding
As at
30 June 2023, the Group had liquidity headroom in the region of
£1,403m, including £787m ($1.0bn) of undrawn RCF, with a
maturity date of October 2027. The pro forma net debt to Adjusted
EBITDA ratio was 2.8x at 30 June 2023 (31 December 2022: 3.2x). The
pro forma net debt to EBITDA ratio was 3.4x at 30 June 2023
(31 December 2022: 4.6x). In July 2023, S&P Global
reaffirmed the Group’s BBB investment grade credit
rating.
The
interest rate on approximately 81% of the Group’s debt
including leases is fixed. The Group has no debt maturities until
November 2024.
Dividend
In view
of our performance in the first half of 2023 and our confidence for
H2, the Board is declaring an interim dividend payment of 2.75p, a
14.6% increase on the prior year period, payable to shareholders on
the register at the close of business on 4 August 2023 and to be
paid on 11 September 2023. The last day for DRIP elections is 18
August 2023.
Notice of Management Change
Brett
Ponton, CEO of our North America Region, is stepping down later
this year to take up the position of CEO of SERVPRO, a
privately-owned property cleanup, restoration, and construction
franchisor. We wish him well and thank him for his commitment and
dedication to bringing together our pest control businesses
following the Terminix transaction. John Myers, CEO of US Pest
Control, continues to lead the Pest Control business in North
America and Brett’s successor will be confirmed in due
course.
Technical guidance update for FY 23
P&L
Restructuring costs
ex Terminix: c.£10m (previously c.£7m)
Deal related costs
and costs to achieve*: c.£80-£100m (previously
c.£75-£90m) due to the 24 deals in H1
Pre-tax net cost
synergies of $60m year over year
Central and
regional overheads: c.£150m including Terminix related
investments
P&L adjusted
interest costs: c.£125m-£135m incl. £20-£25m of
hyperinflation
Estimated Adjusted
Effective Tax Rate: 25-26%
Share of Profits
from Associates: £9m (previously £8m)
Impact of FX**:
within range of -£15m to -£20m (previously +£15m to
£25m)
Intangibles
amortisation: £160-£170m due to more M&A (previously
£155-£165m)
Cash Flow
Overall exceptional
items: c.£135-£145m***
Working Capital:
c.-£60m (previously -£40m) excluding prior year
exceptionals
Capex:
£230-£240m (previously £235-£245m)
Cash interest:
c.£160-£170m (previously c.£150-£160m), due to
higher US interest rates on $700m loan and North America variable
rate leases
Cash tax payments:
£115-£125m
Anticipated spend
on M&A in 2023 of c.£300m (previously c.£250m)
*
Reported as one-off and adjusting items and excluded from Adjusted
Operating Profit and Adjusted PBT
**
Based on maintenance of current FX rates. All technical items are
also subject to FX
***
c.£40m of 2022 exceptional items remained in creditors at
December 2022
Appendix 1
|
|
|
|
|
|
2023 AER
|
||
|
|
Amount
|
Rate
|
Fixed/Floating
|
|
H1£m
|
H2£m
|
Total£m
|
|
Legacy Bonds
|
|
|
|
|
|
|
|
|
EUR
|
400
|
0.950%
|
Fixed
|
|
–
|
–
|
–
|
|
EUR
|
500
|
0.875%
|
Fixed
|
|
–
|
–
|
–
|
|
EUR
|
600
|
0.500%
|
Fixed
|
|
–
|
–
|
–
|
|
Amortised
Cost
|
|
|
Fixed
|
|
1
|
1
|
2
|
|
Swaps
|
|
2.85%
(avg)
|
Fixed
|
|
14
|
14
|
28
|
|
Total
|
1,500
|
|
|
|
15
|
15
|
30
|
|
New Bonds
|
|
|
|
|
|
|
|
|
EUR
|
850
|
3.875%
|
Fixed
|
|
7
|
7
|
14
|
|
EUR
|
600
|
4.375%
|
Fixed
|
|
11
|
11
|
22
|
|
GBP
|
400
|
5.000%
|
Fixed
|
|
10
|
10
|
20
|
|
Amortised
Cost
|
|
|
Fixed
|
|
1
|
2
|
3
|
|
Swaps
|
|
3.53%
(avg)
|
Fixed
|
|
7
|
7
|
14
|
|
Total
|
1,850
|
|
|
|
36
|
37
|
73
|
|
Term Loan
|
|
|
|
|
|
|
|
|
USD
|
700
|
4%-6%
|
50%
Fixed
|
|
15
|
15
|
30
|
|
|
|
|
|
|
|
|
|
|
Lease
Interest
|
|
|
Float
|
|
12
|
11
|
23
|
|
Other
Interest
|
|
|
Float
|
|
6
|
1
|
7
|
|
Total Other
|
|
|
|
|
18
|
12
|
30
|
|
|
|
|
|
|
|
|
|
|
Finance Cost
|
|
|
|
|
84
|
79
|
163
|
|
|
|
|
|
|
|
|
|
|
Interest
received
|
|
|
|
|
(9)
|
–
|
(9)
|
|
Hyperinflation
|
|
|
|
|
(8)
|
(12)
|
(20)
|
|
Finance Income
|
|
|
|
|
(17)
|
(12)
|
(29)
|
|
|
|
|
|
|
|
|
|
|
Adjusted Interest
|
|
|
|
|
67
|
67
|
134
|
AER FX
rate for £/€: 1.1437 and £/$: 1.2357
Appendix 2
Summary of financial performance (at
AER)
Regional Performance
|
|
Revenue
|
|
Adjusted Operating Profit
|
||||
|
|
H1 2023 £m
|
H1 2022 £m
|
Change %
|
|
H1 2023 £m
|
H1 2022 £m
|
Change %
|
|
North America
|
1,654
|
693
|
138.4%
|
|
306
|
111
|
176.0%
|
|
Pest
Control
|
1,609
|
650
|
147.2%
|
|
302
|
105
|
187.2%
|
|
Hygiene
& Wellbeing
|
45
|
43
|
5.1%
|
|
4
|
6
|
(27.2%)
|
|
|
|
|
|
|
|
|
|
|
Europe (inc LATAM)
|
529
|
434
|
22.0%
|
|
97
|
83
|
16.8%
|
|
Pest
Control
|
252
|
189
|
33.1%
|
|
57
|
45
|
26.6%
|
|
Hygiene
& Wellbeing
|
169
|
155
|
9.3%
|
|
22
|
25
|
(12.6%)
|
|
France
Workwear
|
108
|
90
|
20.6%
|
|
18
|
13
|
39.1%
|
|
|
|
|
|
|
|
|
|
|
UK & Sub Saharan Africa
|
190
|
179
|
6.0%
|
|
46
|
46
|
(1.7%)
|
|
Pest
Control
|
97
|
88
|
9.5%
|
|
26
|
21
|
19.2%
|
|
Hygiene
& Wellbeing
|
93
|
91
|
2.5%
|
|
20
|
25
|
(20.0%)
|
|
|
|
|
|
|
|
|
|
|
Asia & MENAT
|
168
|
152
|
10.9%
|
|
23
|
22
|
8.0%
|
|
Pest
Control
|
123
|
107
|
15.3%
|
|
18
|
16
|
13.1%
|
|
Hygiene
& Wellbeing
|
45
|
45
|
0.4%
|
|
5
|
6
|
(5.6%)
|
|
|
|
|
|
|
|
|
|
|
Pacific
|
125
|
109
|
14.8%
|
|
29
|
24
|
20.6%
|
|
Pest
Control
|
63
|
49
|
28.5%
|
|
12
|
8
|
54.2%
|
|
Hygiene
& Wellbeing
|
62
|
60
|
3.7%
|
|
17
|
16
|
4.6%
|
|
|
|
|
|
|
|
|
|
|
Central
|
5
|
5
|
(2.1%)
|
|
(58)
|
(48)
|
(20.2%)
|
|
Restructuring costs
|
|
|
|
|
(6)
|
(5)
|
(14.5%)
|
|
Total at AER
|
2,671
|
1,572
|
69.9%
|
|
437
|
233
|
88.0%
|
Category Performance
|
|
Revenue
|
|
Adjusted Operating Profit
|
||||
|
|
H1 2023 £m
|
H1 2022 £m
|
Change %
|
|
H1 2023 £m
|
H1 2022 £m
|
Change %
|
|
Pest
Control
|
2,144
|
1,083
|
97.7%
|
|
415
|
195
|
112.3%
|
|
Hygiene
& Wellbeing
|
414
|
394
|
5.4%
|
|
68
|
78
|
(11.9%)
|
|
France
Workwear
|
108
|
90
|
20.6%
|
|
18
|
13
|
39.1%
|
|
Central
|
5
|
5
|
(2.1%)
|
|
(58)
|
(48)
|
(20.2%)
|
|
Restructuring
costs
|
|
|
|
|
(6)
|
(5)
|
(14.5%)
|
|
Total at AER
|
2,671
|
1,572
|
69.9%
|
|
437
|
233
|
88.0%
|
Consolidated Statement of Profit or
Loss and Other Comprehensive Income (unaudited)
For the period ended 30 June 2023
|
|
Note
|
6 months to 30 June 2023£m
|
6
months to 30 June 2022£m
|
|
Revenue
|
4
|
2,671
|
1,572
|
|
Operating
expenses
|
|
(2,354)
|
(1,402)
|
|
Net
impairment losses on financial assets
|
|
(13)
|
–
|
|
Operating profit
|
|
304
|
170
|
|
Finance
income
|
|
17
|
7
|
|
Finance
cost
|
|
(88)
|
(20)
|
|
Share
of profit from associates net of tax
|
|
7
|
5
|
|
Profit before income tax
|
|
240
|
162
|
|
Income
tax expense1
|
5
|
(55)
|
(38)
|
|
Profit for the period
|
|
185
|
124
|
|
Profit for the period attributable to:
|
|
|
|
|
Equity
holders of the Company
|
|
185
|
124
|
|
Non-controlling
interests
|
|
–
|
–
|
|
Other comprehensive income:
|
|
|
|
|
Items that are not reclassified subsequently to the income
statement:
|
|
|
|
|
Remeasurement
of net defined benefit liability
|
|
–
|
(2)
|
|
|
|
|
|
|
Items that may be reclassified subsequently to the income
statement:
|
|
|
|
|
Net
exchange adjustments offset in reserves
|
|
(341)
|
214
|
|
Net
gain/(loss) on net investment hedge
|
|
49
|
(66)
|
|
Cost of
hedging
|
|
17
|
5
|
|
Effective
portion of changes in fair value of cash flow hedge
|
|
49
|
(7)
|
|
Tax
related to items taken to other comprehensive income
|
|
2
|
(3)
|
|
Other comprehensive income for the period
|
|
(224)
|
141
|
|
Total comprehensive income for the period
|
|
(39)
|
265
|
|
Total comprehensive income for the period attributable
to:
|
|
|
|
|
Equity
holders of the Company
|
|
(39)
|
265
|
|
Non-controlling
interests
|
|
–
|
–
|
|
|
|
|
|
|
Earnings per share attributable to the Company’s equity
holders:
|
|
|
|
|
Basic
|
|
7.35p
|
6.67p
|
|
Diluted
|
|
7.31p
|
6.65p
|
1.
Taxation includes £55m (2022: £27m) in respect of
overseas taxation.
All
profit is from continuing operations.
The
weighted average number of ordinary shares in issue is 2,513m (HY
2022: 1,860m). For the diluted EPS calculation the adjustment for
share options and LTIPs is 14m (HY 2022: 6m).
Consolidated Balance Sheet (unaudited)
|
|
Note
|
At 30 June 2023
£m
|
At 31
December 2022
£m
|
|
Assets
|
|
|
|
|
Non-current assets
|
|
|
|
|
Intangible
assets
|
|
7,101
|
7,319
|
|
Property,
plant and equipment
|
|
485
|
495
|
|
Right-of-use
assets
|
|
456
|
454
|
|
Investments
in associated undertakings
|
|
43
|
53
|
|
Other
investments
|
|
21
|
23
|
|
Deferred
tax assets
|
|
46
|
43
|
|
Contract
costs
|
|
179
|
182
|
|
Retirement
benefit assets
|
|
6
|
3
|
|
Trade
and other receivables
|
|
88
|
90
|
|
Derivative
financial instruments
|
|
45
|
21
|
|
|
|
8,470
|
8,683
|
|
Current assets
|
|
|
|
|
Other
investments
|
|
1
|
1
|
|
Inventories
|
|
209
|
200
|
|
Trade
and other receivables
|
|
859
|
832
|
|
Current
tax assets
|
|
35
|
36
|
|
Cash
and cash equivalents
|
|
1,418
|
2,170
|
|
|
|
2,522
|
3,239
|
|
Liabilities
|
|
|
|
|
Current liabilities
|
|
|
|
|
Trade
and other payables
|
|
(1,193)
|
(1,162)
|
|
Current
tax liabilities
|
|
(50)
|
(60)
|
|
Provisions
for liabilities and charges
|
|
(125)
|
(133)
|
|
Bank
and other short-term borrowings
|
|
(742)
|
(1,355)
|
|
Lease
liabilities
|
|
(127)
|
(135)
|
|
|
|
(2,237)
|
(2,845)
|
|
Net current assets
|
|
285
|
394
|
|
Non-current liabilities
|
|
|
|
|
Other
payables1
|
|
(76)
|
(81)
|
|
Bank
and other long-term borrowings
|
|
(3,472)
|
(3,574)
|
|
Lease
liabilities
|
|
(325)
|
(332)
|
|
Deferred
tax liabilities
|
|
(503)
|
(511)
|
|
Retirement
benefit obligations
|
|
(30)
|
(30)
|
|
Provisions
for liabilities and charges
|
|
(329)
|
(359)
|
|
Derivative
financial instruments
|
|
(68)
|
(92)
|
|
|
|
(4,803)
|
(4,979)
|
|
Net assets
|
|
3,952
|
4,098
|
|
Equity
|
|
|
|
|
Capital and reserves attributable to the Company’s equity
holders
|
|
|
|
|
Share
capital
|
|
25
|
25
|
|
Share
premium
|
|
12
|
9
|
|
Other
reserves
|
|
537
|
763
|
|
Retained
earnings
|
|
3,379
|
3,302
|
|
|
|
3,953
|
4,099
|
|
Non-controlling
interests
|
|
(1)
|
(1)
|
|
Total equity
|
|
3,952
|
4,098
|
1.
Non-current other payables includes £33m put option liability
related to the PCI India acquisition (2022:
£43m).
Consolidated Statement of Changes in Equity
(unaudited)
|
|
Attributable
to equity holders of the Company
|
|
|
|||
|
|
Share
capital
£m
|
Share
premium
£m
|
Other
reserves
£m
|
Retained
earnings
£m
|
Non-
controlling
interests
£m
|
Total
equity
£m
|
|
At 1
January 2022
|
19
|
7
|
(1,927)
|
3,166
|
(1)
|
1,264
|
|
Profit
for the period
|
–
|
–
|
–
|
124
|
–
|
124
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
Net
exchange adjustments offset in reserves
|
–
|
–
|
214
|
–
|
–
|
214
|
|
Net
loss on net investment hedge
|
–
|
–
|
(66)
|
–
|
–
|
(66)
|
|
Net
loss on cash flow hedge1
|
–
|
–
|
(7)
|
–
|
–
|
(7)
|
|
Cost of
hedging
|
–
|
–
|
4
|
–
|
–
|
4
|
|
Remeasurement
of net defined benefit asset
|
–
|
–
|
–
|
(2)
|
–
|
(2)
|
|
Tax
related to items taken directly to other comprehensive
income
|
–
|
–
|
–
|
(2)
|
–
|
(2)
|
|
Total
comprehensive income for the period
|
–
|
–
|
145
|
120
|
–
|
265
|
|
Transactions with owners:
|
|
|
|
|
|
|
|
Cost of
issuing new shares
|
–
|
–
|
–
|
(13)
|
–
|
(13)
|
|
Dividends
paid to equity shareholders
|
–
|
–
|
–
|
(80)
|
–
|
(80)
|
|
Cost of
equity-settled share-based payment plans
|
–
|
–
|
–
|
5
|
–
|
5
|
|
Tax
related to items taken directly to equity
|
–
|
–
|
–
|
(4)
|
–
|
(4)
|
|
Movement
in the carrying value of put options
|
–
|
–
|
–
|
1
|
–
|
1
|
|
At 30
June 2022
|
19
|
7
|
(1,782)
|
3,195
|
(1)
|
1,438
|
|
At 1
January 2023
|
25
|
9
|
763
|
3,302
|
(1)
|
4,098
|
|
Profit
for the period
|
–
|
–
|
–
|
185
|
–
|
185
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
Net
exchange adjustments offset in reserves
|
–
|
–
|
(341)
|
–
|
–
|
(341)
|
|
Net
gain on net investment hedge
|
–
|
–
|
49
|
–
|
–
|
49
|
|
Net
gain on cash flow hedge1
|
–
|
–
|
49
|
–
|
–
|
49
|
|
Cost of
hedging
|
–
|
–
|
17
|
–
|
–
|
17
|
|
Tax
related to items taken directly to other comprehensive
income
|
–
|
–
|
–
|
2
|
–
|
2
|
|
Total
comprehensive income for the period
|
–
|
–
|
(226)
|
187
|
–
|
(39)
|
|
Transactions with owners:
|
|
|
|
|
|
|
|
Gain on
stock options
|
–
|
3
|
–
|
–
|
–
|
3
|
|
Dividends
paid to equity shareholders
|
–
|
–
|
–
|
(131)
|
–
|
(131)
|
|
Cost of
equity-settled share-based payment plans
|
–
|
–
|
–
|
14
|
–
|
14
|
|
Tax
related to items taken directly to equity
|
–
|
–
|
–
|
4
|
–
|
4
|
|
Movement
in the carrying value of put options
|
–
|
–
|
–
|
3
|
–
|
3
|
|
At 30 June 2023
|
25
|
12
|
537
|
3,379
|
(1)
|
3,952
|
1.
£49m net gain on cash flow hedge includes £nil gain/loss
(2022: £7m gain) from the effective portion of changes in fair
value offset by reclassification to the income statement of
£49m gain (2022: £14m gain) due to changes in foreign
exchange rates.
Shares
of £nil (2022: £nil) have been netted against retained
earnings. This represents 14.5m (2022: 12.3m) shares held by the
Rentokil Initial Employee Share Trust. The market value of these
shares at 30 June 2023 was £89m (2022: £58m). Dividend
income from, and voting rights on, the shares held by the Trust
have been waived.
Analysis of other reserves
(unaudited)
|
|
Capital
reduction reserve £m
|
Merger
relief
reserve
£m
|
Cash
flow hedge reserve £m
|
Translation
reserve£m
|
Cost of
hedging £m
|
Total
£m
|
|
At 1
January 2022
|
(1,723)
|
–
|
9
|
(211)
|
(2)
|
(1,927)
|
|
Net
exchange adjustments offset in reserves
|
–
|
–
|
–
|
214
|
–
|
214
|
|
Net
loss on net investment hedge
|
–
|
–
|
–
|
(66)
|
–
|
(66)
|
|
Net
loss on cash flow hedge1
|
–
|
–
|
(7)
|
–
|
–
|
(7)
|
|
Cost of
hedging
|
–
|
–
|
–
|
–
|
4
|
4
|
|
Total
comprehensive income for the period
|
–
|
–
|
(7)
|
148
|
4
|
145
|
|
At 30
June 2022
|
(1,723)
|
–
|
2
|
(63)
|
2
|
(1,782)
|
|
At 1
January 2023
|
(1,723)
|
2,998
|
3
|
(511)
|
(4)
|
763
|
|
Net
exchange adjustments offset in reserves
|
–
|
–
|
–
|
(341)
|
–
|
(341)
|
|
Net
gain on net investment hedge
|
–
|
–
|
–
|
49
|
–
|
49
|
|
Net
gain on cash flow hedge1
|
–
|
–
|
49
|
–
|
–
|
49
|
|
Cost of
hedging
|
–
|
–
|
–
|
–
|
17
|
17
|
|
Total
comprehensive income for the period
|
–
|
–
|
49
|
(292)
|
17
|
(226)
|
|
At 30 June 2023
|
(1,723)
|
2,998
|
52
|
(803)
|
13
|
537
|
1.
£49m net gain on cash flow hedge includes £nil gain/loss
(2022: £7m gain) from the effective portion of changes in fair
value offset by reclassification to the income statement of
£49m gain (2022: £14m gain) due to changes in foreign
exchange rates.
Consolidated Cash Flow Statement (unaudited)
|
|
Note
|
6 months to30 June2023 £m
|
6
months to 30 June 2022 £m
|
|
Cash flows from operating activities
|
|
|
|
|
Cash
generated from operating activities
|
12
|
504
|
312
|
|
Interest
received
|
|
8
|
2
|
|
Interest
paid1
|
|
(122)
|
(21)
|
|
Income
tax paid
|
|
(58)
|
(32)
|
|
Net
cash flows from operating activities
|
|
332
|
261
|
|
Cash flows from investing activities
|
|
|
|
|
Purchase
of property, plant and equipment
|
|
(81)
|
(68)
|
|
Purchase
of intangible fixed assets
|
|
(21)
|
(15)
|
|
Proceeds
from sale of property, plant and equipment
|
|
2
|
3
|
|
Acquisition
of companies and businesses, net of cash acquired
|
|
(175)
|
(127)
|
|
Net
change to cash flow from investment in term deposits
|
|
–
|
(2)
|
|
Net
cash flows from investing activities
|
|
(275)
|
(209)
|
|
Cash flows from financing activities
|
|
|
|
|
Dividends
paid to equity shareholders
|
|
(131)
|
(80)
|
|
Capital
element of lease payments
|
|
(82)
|
(45)
|
|
Cost of
issuing new shares
|
|
–
|
(13)
|
|
Cash
(outflow)/inflow on settlement of debt-related foreign exchange
forward contracts
|
|
(3)
|
1
|
|
Proceeds
from new debt
|
|
–
|
1,744
|
|
Debt
repayments
|
|
–
|
(136)
|
|
Net
cash flows from financing activities
|
|
(216)
|
1,471
|
|
Net
(decrease)/increase in cash and cash equivalents
|
|
(159)
|
1,523
|
|
Cash
and cash equivalents at beginning of period
|
|
879
|
242
|
|
Exchange
(loss)/gain on cash and cash equivalents
|
|
(22)
|
23
|
|
Cash and cash equivalents at end of the financial
period
|
|
698
|
1,788
|
1.
Interest paid includes the interest element of lease payments of
£12m (2022: £3m).
Explanatory notes to the interim
financial statements (unaudited)
1. General information
The
Company is a public limited company incorporated in England and
Wales and domiciled in the UK with a listing on the London Stock
Exchange. The address of its registered office is Rentokil Initial
plc, Compass House, Manor Royal, Crawley, West Sussex, RH10
9PY.
The
consolidated half-yearly financial information for the half-year to
30 June 2023 was approved on 26 July 2023 for issue on 27 July
2023.
On page
101 of the Annual Report 2022 we set out the Group’s approach
to risk management and on pages 63 to 69 we define the principal
risks that are most relevant to the Group. These risks are
described in detail and have mitigating actions assigned to each of
them. In our view the principal risks remain unchanged from those
indicated in the Annual Report 2022. A summary of the risks is laid
out in the table below:
|
Principal risk
|
Summary of risk
|
|
Failure
to integrate acquisitions and execute disposals from continuing
business
|
The
Company has a strategy that includes growth by acquisition, and has
acquired 24 businesses in H1 2023. These companies need to be
integrated quickly and efficiently to minimise potential impact on
the acquired business and the existing business.
|
|
Failure
to develop products and services that are tailored and relevant to
local markets and market conditions
|
The
Company operates across markets that are at different stages in the
economic cycle, at varying stages of market development and have
different levels of market attractiveness. We must be sufficiently
agile to develop and deliver products and services that meet local
market needs.
|
|
Failure
to grow our business profitably in a changing macro-economic
environment
|
The
Company’s two core categories (Pest Control and Hygiene &
Wellbeing) operate in a global macro-economic environment that is
subject to uncertainty and volatility.
|
|
Failure
to mitigate against financial market risks
|
Our
business is exposed to foreign exchange risk, interest rate risk,
liquidity risk, counterparty risk and settlement risk.
|
|
Breaches
of laws or regulations (including tax, competition and anti-trust
laws)
|
As a
responsible company we aim to comply with all laws and regulations
that apply to our businesses across the globe.
|
|
Failure
to ensure business continuity in case of a material
incident
|
The
business needs to have resilience to ensure business can continue
if impacted by external events, e.g. cyber attack, hurricane or
terrorism.
|
|
Fraud,
financial crime and loss or unintended release of personal
data
|
Collusion
between individuals, both internal and external, could result in
fraud if internal controls are not in place and working
effectively. The business holds personal data on colleagues, some
customers and suppliers: unintended loss or release of such data
may result in criminal sanctions.
|
|
Safety,
health and the environment (SHE)
|
The
Company has an obligation to ensure that colleagues, customers and
other stakeholders remain safe, that the working environment is not
detrimental to health and that we are aware of and minimise any
adverse impact on the environment.
|
|
Failure
to deliver consistently high levels of service to the satisfaction
of our customers
|
Our
business model depends on servicing the needs of our customers in
line with internal high standards and to levels agreed in
contracts.
|
These
interim financial results do not comprise statutory accounts within
the meaning of Section 435 of the Companies Act 2006, and should be
read in conjunction with the Annual Report 2022. Those accounts
have been audited and delivered to the registrar of companies. The
report of the auditor was unqualified, did not include a reference
to any matters to which the auditor drew attention by way of
emphasis without qualifying their report and did not contain
statements under section 498(2) or (3) of the Companies Act
2006.
For all information relating to 2022 results please refer to the
Annual Report 2022 which can be accessed here:
https://www.rentokil-initial.com/investors/annual-reports.aspx
2. Basis of preparation
The
condensed consolidated financial statements have been prepared in
accordance with the Disclosure and Transparency Rules of the
Financial Conduct Authority and in accordance with IAS 34 Interim
Financial Reporting as contained in UK-adopted international
accounting standards. The condensed consolidated financial
statements should be read in conjunction with the annual financial
statements for the year ended 31 December 2022 which have been
prepared in accordance with UK-adopted International Accounting
Standards and with the requirements of the Companies Act 2006 as
applicable to companies reporting under those standards. The annual
financial statements for the year ended 31 December 2022 and the
condensed consolidated financial statements also comply fully with
International Financial Reporting Standards (IFRSs) as issued by
the International Accounting Standards Board (IASB).
Going concern
The
Directors have prepared Board-approved cash flow forecasts that
demonstrate that the Group has sufficient liquidity to meet its
obligations as they fall due for the period of at least 12 months
from the date of approval of these Financial
Statements.
Additionally,
the Directors have assessed severe but plausible downside
scenarios. The downside scenarios include a revenue decline of 20%
against base budget for six months or for 12 months, and a one off
‘shock’ in the form of a cash loss of £200m. All
of these scenarios are considerably worse than the actual impact of
the COVID-19 pandemic in 2020. Starting with c£1.4bn of
headroom at June 2023, none of the scenarios required additional
external funding above and beyond existing committed facilities and
in the most severe downside scenario the minimum headroom modelled
was c.£0.95bn before the inclusion of mitigating actions
totalling £0.3bn, such as cost savings, adjusting the level of
M&A activity and/or dividends paid, which are all within the
Group’s control and were used during the COVID-19
pandemic.
The
Directors have therefore concluded that the Group will have
sufficient liquidity to continue to meet its liabilities as they
fall due for this period and therefore have prepared the Financial
Statements on a going concern basis.
3. Accounting policies
The
Group makes estimates and assumptions concerning the future.
Estimates and assumptions are continually evaluated and are based
on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the
circumstances. Actual results may differ from these estimates and
revisions to estimates are recognised prospectively. Sensitivities
to the estimates and assumptions are provided, where relevant, in
the notes to the financial statements.
The
estimates and assumptions that have a significant risk of causing a
material adjustment to the carrying amounts of assets and
liabilities within the next financial year are listed
below:
|
●
|
Termite
damage claim provisions
|
Provisions
for uncertain tax positions is no longer considered to have a
significant risk of causing a material adjustment to the carrying
amounts of assets and liabilities within the next financial
year.
Further
detail can be found in the Annual Report 2022.
Significant
seasonal or cyclical variations in the Group’s total revenues
are not experienced during the financial year.
Changes in accounting policies
Except
as described below, the accounting policies applied in these
interim financial statements are the same as those applied in the
Group’s consolidated financial statements as at and for the
year ended 31 December 2022. The changes in accounting policies are
also expected to be reflected in the Group’s consolidated
financial statements as at and for the year ending 31 December
2023.
A
number of new standards are effective from 1 January 2023 but they
do not have a material effect on the Group’s financial
statements.
The
Group has adopted the following amendments to standards with effect
from 1 January 2023:
|
●
|
Insurance
contracts (for non-insurers) – Introduction of IFRS
17
|
|
●
|
Definition
of accounting estimates – Amendments to IAS 8
|
|
●
|
Disclosure
of accounting policies – Amendments to IAS 1
|
|
●
|
Deferred
tax – Amendments to IAS 12.
|
These
standards have had no material impact on the financial position or
performance of the Group. Consequently, no adjustment has been made
to the comparative financial information. The Group has not early
adopted any standard, interpretation or amendment that was issued
but is not yet effective.
4. Segmental information
Segment reporting
Segmental
information has been presented in accordance with IFRS 8 Operating
Segments. The Group’s operating segments are regions and this
reflects the internal management reporting structures and the way
information is reviewed by the chief operating decision maker (the
Chief Executive). Each region is headed by a Regional Managing
Director who reports directly to the Chief Executive and is a
member of the Group’s Executive Leadership Team responsible
for the review of Group performance. The businesses within each
operating segment operate in a number of different countries and
sell services across three business segments.
Effective
from 1 January 2022, in response to the rising importance of
hygiene and wellbeing services, Rentokil Initial reorganised its
business segments, primarily expanding the former Hygiene segment
to become Hygiene & Wellbeing and allocating the businesses in
its former Protect & Enhance segment. The Protect & Enhance
segment had included five businesses: Ambius, Property Care, Dental
Services, Cleanroom Services and Workwear (France). The Ambius,
Dental Services and Cleanroom Services businesses have been added
to the enlarged segment, now called Hygiene & Wellbeing, the
Property Care business has been added to the Pest Control segment,
and Workwear (France) has been left as a standalone segment. At the
same time, changes were made to the regional structure, designed to
provide clearer geographic links and align growth strategies, as
follows:
|
●
|
North
America: Puerto Rico joined the Latin America (LATAM)
region
|
|
●
|
Europe:
Includes Nordics (Norway, Sweden, Finland, Denmark and Poland),
previously in UK & Rest of World region. Also continues to
include LATAM¹ which has been expanded to include Caribbean
(formerly in UK & Rest of World) and Puerto Rico (formerly in
North America)
|
|
●
|
UK
& Sub-Saharan Africa: No change to UK, Ireland & Baltics.
Sub-Saharan Africa remained in this region. Other Rest of World
countries (MENAT and Caribbean) moved to other regions
|
|
●
|
Asia
& MENAT: Enlarged region includes Asia and MENAT
countries
|
|
●
|
Pacific:
No change
|
1. The
LATAM region is combined with Europe. It is the Group’s
smallest region and not considered reportable under the
quantitative thresholds in IFRS 8. It is combined with Europe as it
historically reported through this region, it is similar in nature
to the Europe businesses and has language and cultural
alignment.
The
financial information presented has been retrospectively adjusted
to reflect these changes.
Disaggregated
revenue under IFRS 15 is the same as the segmental analysis below.
Restructuring costs and central and regional costs are presented at
a Group level as they are not targeted or managed at reportable
segment level. The basis of presentation is consistent with the
information reviewed by internal management.
Adjusted profit measures
Adjusted
profit measures are used to give management and other users of the
accounts a clear understanding of the underlying profitability of
the business over time. Adjusted profit measures are calculated by
adding the following items back to the equivalent GAAP profit
measure:
|
●
|
amortisation
and impairment of intangible assets (excluding computer
software);
|
|
●
|
one-off
and adjusting items; and
|
|
●
|
net
interest adjustments.
|
Intangible
assets (such as customer lists and brands) are recognised on
acquisition of businesses which, by their nature, can vary by size
and amount each year. Capitalisation of innovation-related
development costs will also vary from year to year. As a result,
amortisation of intangibles is added back to assist with
understanding the underlying trading performance of the business
and to allow comparability across regions and
categories.
One-off
and adjusting items are significant expenses or income that will
have a distortive impact on the underlying profitability of the
Group. Typical examples are costs related to the acquisition of
businesses, gain or loss on disposal or closure of a business,
material gains or losses on disposal of fixed assets, adjustments
to legacy property-related provisions (environmental liabilities),
and payments or receipts as a result of legal
disputes.
Net
interest adjustments are other non-cash or one-off accounting gains
and losses that can cause material fluctuations and distort
understanding of the performance of the business, such as net
interest on pension schemes and interest fair value adjustments.
These adjustments are made to aid year-on-year
comparability.
Diluted
Adjusted Earnings Per Share is calculated by dividing adjusted
profit after tax from continuing operations attributable to equity
holders of the Company by the weighted average diluted number of
ordinary shares in issue.
Revenue and profit from continuing operations
|
|
Revenue
30 June
2023
£m
|
Revenue¹
30
June
2022
£m
|
Operating
profit
30 June
2023
£m
|
Operating
profit¹
30
June
2022
£m
|
|
North America
|
|
|
|
|
|
Pest
Control
|
1,609
|
650
|
302
|
105
|
|
Hygiene
& Wellbeing
|
45
|
43
|
4
|
6
|
|
|
1,654
|
693
|
306
|
111
|
|
Europe (incl LATAM)
|
|
|
|
|
|
Pest
Control
|
252
|
189
|
57
|
45
|
|
Hygiene
& Wellbeing
|
169
|
155
|
22
|
25
|
|
France
Workwear
|
108
|
90
|
18
|
13
|
|
|
529
|
434
|
97
|
83
|
|
UK & Sub-Saharan Africa
|
|
|
|
|
|
Pest
Control
|
97
|
88
|
26
|
21
|
|
Hygiene
& Wellbeing
|
93
|
91
|
20
|
25
|
|
|
190
|
179
|
46
|
46
|
|
Asia & MENAT
|
|
|
|
|
|
Pest
Control
|
123
|
107
|
18
|
16
|
|
Hygiene
& Wellbeing
|
45
|
45
|
5
|
6
|
|
|
168
|
152
|
23
|
22
|
|
Pacific
|
|
|
|
|
|
Pest
Control
|
63
|
49
|
12
|
8
|
|
Hygiene
& Wellbeing
|
62
|
60
|
17
|
16
|
|
|
125
|
109
|
29
|
24
|
|
Central and regional overheads
|
5
|
5
|
(58)
|
(48)
|
|
Restructuring costs
|
–
|
–
|
(6)
|
(5)
|
|
Revenue and Adjusted Operating Profit
|
2,671
|
1,572
|
437
|
233
|
|
Adjusted
Operating Profit Margin
|
|
|
16.4%
|
14.8%
|
|
One-off
and adjusting items
|
|
|
(46)
|
(23)
|
|
Amortisation
and impairment of intangible assets2
|
|
|
(87)
|
(40)
|
|
Operating Profit
|
|
|
304
|
170
|
|
Operating
Profit Margin
|
|
|
11.4%
|
10.8%
|
|
Share
of profit from associates (net of tax)
|
|
|
7
|
5
|
|
Adjusted
interest
|
|
|
(67)
|
(12)
|
|
Net
interest adjustments
|
|
|
(4)
|
(1)
|
|
Profit Before Tax
|
|
|
240
|
162
|
|
Net
interest adjustments
|
|
|
4
|
1
|
|
One-off
and adjusting items
|
|
|
46
|
23
|
|
Amortisation
and impairment of intangible assets1
|
|
|
87
|
40
|
|
Adjusted Profit Before Tax
|
|
|
377
|
226
|
1.
During 2022, internal management reporting structures changed and
revenue and profit have been represented for 2022 under the new
structure.
2.
Excluding computer software.
Organic Revenue measures
Acquisitions
are a core part of the Group’s growth strategy. Organic
Revenue growth measures are used to help understand the underlying
performance of the Group. Organic Revenue growth represents the
growth in Revenue excluding the effect of businesses acquired
during the period. Acquired businesses are included in organic
measures in the period following acquisition, and the comparative
period is adjusted to include an estimated full-year performance
for growth calculations (pro forma revenue). The Terminix
acquisition is treated differently to other acquisitions for
Organic Revenue growth purposes, with the growth in Revenue not
being excluded. The full pre-acquisition results of the Terminix
business are included for the comparative period and Organic
Revenue growth calculated as the growth in Revenue compared with
the comparative period.
|
|
Organic Revenue growth
excluding disinfection
|
Organic Revenue growth
including disinfection
|
||
|
|
30 June
2023
%
|
30
June
2022
%
|
30 June
2023
%
|
30
June
2022
%
|
|
North
America
|
4.1
|
5.7
|
4.1
|
1.0
|
|
Europe
(incl LATAM)
|
11.1
|
9.5
|
9.8
|
5.0
|
|
UK
& Sub-Saharan Africa
|
3.9
|
5.9
|
3.9
|
3.2
|
|
Asia
& MENAT
|
11.3
|
8.0
|
6.5
|
5.4
|
|
Pacific
|
7.4
|
5.3
|
7.3
|
4.8
|
|
Group
|
5.9
|
6.2
|
5.4
|
2.0
|
|
|
|
|
|
|
|
Pest
Control
|
5.6
|
5.1
|
5.6
|
5.1
|
|
Hygiene
& Wellbeing
|
5.2
|
10.1
|
1.8
|
(12.2)
|
|
France
Workwear
|
16.3
|
15.5
|
16.3
|
15.5
|
|
Group
|
5.9
|
6.2
|
5.4
|
2.0
|
Analysis of revenue by type
|
|
Revenue
30 June
2023
£m
|
Revenue
30
June
2022
£m
|
|
Recognised over time
|
|
|
|
Contract
service revenue
|
1,918
|
1,110
|
|
Recognised at a point in time
|
|
|
|
Job
work
|
541
|
289
|
|
Sales
of goods
|
212
|
173
|
|
Total
|
2,671
|
1,572
|
One-off and adjusting items – operating
One-off
and adjusting items – operating is a charge of £46m
(2022: £23m) which mainly relates to acquisition and
integration costs, £35m of which relates to the Terminix
acquisition (2022: £19m).
Other
segment items included in the consolidated income statement are as
follows:
|
|
Amortisation and
impairment of
intangibles1
30 June 2023
£m
|
Amortisation
and
impairment
of
intangibles1
30 June
2022
£m
|
|
North
America
|
58
|
20
|
|
Europe
(incl. LATAM)
|
13
|
7
|
|
UK
& Sub-Saharan Africa
|
4
|
4
|
|
Asia
& MENAT
|
5
|
5
|
|
Pacific
|
3
|
2
|
|
Central
and regional
|
4
|
2
|
|
Total
|
87
|
40
|
1.
Excluding computer software.
5. Income tax expense
Analysis
of charge in the period:
|
|
6 months to
30 June
2023
£m
|
6
months to
30
June
2022
£m
|
|
UK
corporation tax at 23.5% (2022: 19.0%; 2021: 19.0%)
|
2
|
9
|
|
Overseas
taxation
|
44
|
40
|
|
Adjustment
in respect of previous periods
|
(2)
|
(2)
|
|
Total current tax
|
44
|
47
|
|
Deferred
tax expense/(credit)
|
13
|
(9)
|
|
Deferred
tax adjustment from change in tax rates
|
–
|
–
|
|
Adjustment
in respect of previous periods
|
(2)
|
–
|
|
Total deferred tax
|
11
|
(9)
|
|
Total income tax expense
|
55
|
38
|
The tax
charge for the period has been calculated by applying the effective
tax rate which is expected to apply to the Group for the year ended
31 December 2023 using rates substantively enacted by 30 June 2023.
A separate effective income tax rate has been calculated for each
jurisdiction in which the Group operates applied to the pre tax
profits for the interim period.
The
reported tax rate for the period was 22.9% (H1 2022: 23.2%). The
Group’s Effective Tax Rate (ETR) before amortisation of
intangible assets (excluding computer software), one-off items and
the net interest adjustments for the period was 23.4% (H1 2022:
21.8%). This compares with a blended rate of tax for the countries
in which the Group operates of 25% (H1 2022: 24%).
Legislation,
which has been enacted at the balance sheet date, increases the
standard rate of UK corporation tax from 19% to 25% from 1 April
2023. Deferred tax balances have been calculated using the tax
rates upon which the balance is expected to unwind.
The
Group’s ETR is expected to increase towards the blended tax
rate due to the high proportion of profits arising in the UK and
US. The blended tax rate is expected to remain at 25% in
2024.
On 20
June 2023, Finance (No.2) Act 2023 was substantively enacted in the
UK, introducing a global minimum effective tax rate of 15%. The
legislation implements a domestic top-up tax and a multinational
top-up tax, effective for accounting periods starting on or after
31 December 2023. The Group has applied the exception under the
proposed IAS 12 amendment to recognising and disclosing information
about deferred tax assets and liabilities related to top-up income
taxes.
Total
uncertain tax positions (including interest thereon) amounted to
£50m as at 30 June 2023 (2022: £54m). Included within
this amount is £6m (2022: £6m) in respect of interest
arising on tax provisions, which is included within other
payables.
Total
tax payments for the period amounted to £58m (H1 2022:
£32m), an increase of £26m.
The
movement on the deferred income tax account is as
follows:
|
|
6 months to
30 June
2023
£m
|
6
months to
30
June
2022
£m
|
|
At 1
January
|
(468)
|
(67)
|
|
Exchange
differences
|
24
|
(7)
|
|
Acquisition
of companies and businesses
|
(7)
|
(16)
|
|
(Charged)/credited
to the income statement
|
(11)
|
10
|
|
Credited
to other comprehensive income
|
1
|
–
|
|
Credited/(charged)
to equity
|
4
|
(4)
|
|
At 30 June
|
(457)
|
(84)
|
|
Deferred
taxation has been presented on the balance sheet as
follows:
|
|
|
|
Deferred
tax asset within non-current assets
|
46
|
44
|
|
Deferred
tax liability within non-current liabilities
|
(503)
|
(128)
|
|
|
(457)
|
(84)
|
A
deferred tax asset of £27m has been recognised in respect of
losses (2022: £23m), of which £21m (2022: £18m)
relates to UK losses carried forward at 30 June 2023. This amount
has been calculated by estimating the future UK taxable profits,
against which the UK tax losses will be utilised, progressively
risk weighted, and applying the tax rates (substantively enacted as
at the balance sheet date) applicable for each year. Remaining UK
tax losses of £82m (2022: £120m) have not been recognised
as at 30 June 2023 as it is not considered probable that future
taxable profits will be available against which the tax losses can
be offset.
At the
balance sheet date the Group had tax losses of £191m (2022:
£230m) on which no deferred tax asset is recognised because it
is not considered probable that future taxable profits will be
available in certain jurisdictions to be able to benefit from those
tax losses.
Adjusted effective tax rate
Adjusted
effective tax rate is calculated by dividing adjusted income tax
expense by adjusted profit before tax, expressed as a percentage.
The measure is used by management to assess the rate of tax applied
to the Group’s adjusted profit before tax from continuing
operations.
|
|
6 months to
30 June
2023
AER
£m
|
6
months to
30
June
2022
AER/CER
£m
|
|
Unadjusted
income tax expense
|
54
|
38
|
|
Tax adjustments on:
|
|
|
|
Amortisation
and impairment of intangible assets (excluding computer
software)
|
21
|
10
|
|
One-off
and adjusting items – operating
|
12
|
1
|
|
Net
interest adjustments
|
1
|
–
|
|
Adjusted income tax expense (a)
|
88
|
49
|
|
Adjusted
profit before tax (b)
|
377
|
226
|
|
Adjusted effective tax rate (a/b)
|
23.4%
|
21.8%
|
6. Dividends
Dividend
distribution to the Company’s shareholders is recognised as a
liability in the Group’s financial statements in the period
in which the dividends are approved by the Company’s
shareholders. Interim dividends are recognised when
paid.
|
|
6 months to
30 June
2023
£m
|
6
months to
30
June
2022
£m
|
|
2021
final dividend paid – 4.30p per share
|
–
|
80
|
|
2022
final dividend paid – 5.15p per share
|
131
|
–
|
|
Total
|
131
|
80
|
The
directors have declared an interim dividend of 2.75p per share
amounting to £69m payable on 11 September 2023 to shareholders
on the register at close of business on 4 August 2023. The last day
for DRIP elections is 18 August 2023. The Company has a progressive
dividend policy and will consider the level of growth for 2023
based on the year-end results. These interim financial statements
do not reflect this dividend payable.
7. Business combinations
During
the period the Group purchased 100% of the share capital or trade
and assets of 24 companies and businesses (2022: 31). An overview
of the acquisitions in the year can be found on page 9 under the
'Continued excellent execution on bolt-on M&A' heading. The
Group acquires companies and businesses as part of its growth
strategy.
The
total consideration in respect of these acquisitions was £202m
(2022: £160m).
Details
of goodwill and the fair value of net assets acquired in the period
are as follows:
|
|
6 months to
30 June
2023
£m
|
6
months to
30
June
2022
£m
|
|
Purchase consideration
|
|
|
|
–
Cash paid
|
161
|
116
|
|
–
Deferred and contingent consideration
|
41
|
44
|
|
Total purchase consideration
|
202
|
160
|
|
Fair
value of net assets acquired
|
58
|
73
|
|
Goodwill from current-period acquisitions
|
144
|
87
|
Goodwill
represents the synergies and other benefits expected to be realised
from integrating acquired businesses into the Group, such as
improved route density, expansion in use of best-in-class digital
tools and back office synergies.
Deferred
consideration of £8m and contingent consideration of £33m
are payable in respect of the above acquisitions (2022: £17m
and £27m respectively). Contingent consideration is payable
based on a variety of conditions including revenue and profit
targets being met. During the period there were releases of
contingent consideration liabilities not paid of £nil (2022:
£1m).
The
provisional fair values1 of assets and
liabilities arising from acquisitions in the period are as
follows:
|
|
6 months to
30 June
2023
£m
|
6
months to
30
June
2022
£m
|
|
Non-current
assets
|
|
|
|
–
Intangible assets2
|
47
|
71
|
|
–
Property, plant and equipment
|
11
|
7
|
|
Current
assets
|
19
|
17
|
|
Current
liabilities
|
(10)
|
(6)
|
|
Non-current
liabilities
|
(9)
|
(16)
|
|
Net assets acquired
|
58
|
73
|
1. The
provisional fair values will be finalised in the 2023 financial
statements. The fair values are provisional since the acquisition
accounting has not yet been finalised, primarily due to the
proximity of many acquisitions to the period end.
2.
Includes £39m (2022: £68m) of customer lists and £8m
(2022: £3m) of other intangibles.
Acquired
receivables are disclosed at fair value and represent the best
estimate of the contractual cash flows expected to be
collected.
From
the dates of acquisition to 30 June 2023, these acquisitions
contributed £28m to revenue and £6m to operating profit
(2022: £14m and £3m respectively). If the acquisitions
had occurred on 1 January 2023, the revenue and operating profit of
the Group would have amounted to £2,686m and £307m
respectively (2022: £1,590m and £172m
respectively).
In
relation to prior period acquisitions, there has been an adjustment
to the provisional fair values of the Terminix acquisition
resulting in an increase to goodwill of £14m. This is made up
of £10m reduction in the fair value of acquired investments in
associates and various other minor adjustments resulting in a
£4m decrease in the fair value of acquired net assets. The
Terminix opening balance sheet is still provisional at 30 June
2023.
The
Group paid £21m in respect of deferred and contingent
consideration for current and prior year acquisitions (2022:
£19m), resulting in the total cash outflow in the period from
current and past period acquisitions, net of £7m (2022:
£7m) cash acquired, of £175m (2022:
£127m).
8. Goodwill
Goodwill
represents the excess of the cost of an acquisition over the fair
value of the Group’s share of the net identifiable assets of
the acquired business at the date of acquisition. It is recognised
as an intangible asset. Goodwill arising on the acquisition of an
associate is included in investments in associates.
Goodwill
is carried at cost less accumulated impairment losses and is tested
annually for impairment. For the purpose of impairment testing,
goodwill is allocated to cash-generating units (CGUs) identified
according to country of operation and reportable business unit. The
way in which CGUs are identified has not changed from prior
periods. Newly acquired entities might be a single CGU until such
time that they can be integrated. Gains and losses on the disposal
of an entity include the carrying amount of goodwill relating to
the entity sold.
The
recoverable amount of a CGU is determined based on the higher of
value-in-use calculations using cash flow projections and fair
value less costs to sell if appropriate. The cash flow projections
in year one are based on financial budgets approved by management,
which are prepared as part of the Group’s normal planning
process. Cash flows for years two to five use management’s
expectation of sales growth, operating costs and margin, based on
past experience and expectations regarding future performance and
profitability for each CGU. Cash flows beyond the five-year period
are extrapolated using estimated long-term growth rates. The effect
of climate change has been considered in the cash
flows.
An
assessment has been performed for all material CGUs at the half
year to identify any possible indicators of impairment. The
assessment included a review of internal and external factors that
have the potential to significantly reduce the CGU value. The
indicator assessment resulted in two CGUs showing possible
indicators of impairment, and as a result a full impairment
assessment was undertaken for those CGUs. The impairment assessment
identified a total of £4m of goodwill impairments across 2
CGUs.
9. Net debt
Reconciliation
of net change in cash and cash equivalents to net
debt:
|
|
At 30 June
2023 £m
|
At 31
December
2022
£m
|
|
Current
|
|
|
|
Cash
and cash equivalents in the Consolidated Balance Sheet
|
1,418
|
2,170
|
|
Other
investments
|
1
|
1
|
|
Bank
and other short-term borrowings¹
|
(742)
|
(1,355)
|
|
Lease
liabilities
|
(127)
|
(135)
|
|
|
550
|
681
|
|
Non-current
|
|
|
|
Fair
value of debt-related derivatives
|
(23)
|
(71)
|
|
Bank
and other long-term borrowings²
|
(3,472)
|
(3,574)
|
|
Lease
liabilities
|
(325)
|
(332)
|
|
|
(3,820)
|
(3,977)
|
|
Total net debt
|
(3,270)
|
(3,296)
|
1. Bank
and other short-term borrowings consists of £720m overdraft
(2022: £1,291m), £16m overseas loans (2022: £24m)
and £6m bond accruals (2022: £40m).
2. Bank
and other long-term borrowings consists of £2,914m bond debt
(2022: £2,987m) and £558m loans (2022:
£587m).
Fair
value is equal to carrying value for all elements of net debt with
the exception of bond debt which has a carrying value of
£2,914m (December 2022: £2,987m) and a fair value of
£2,774m (December 2022: £2,826m). No further disclosures
are required by IFRS 7.29(a).
Cash at
bank and in hand includes £14m (December 2022: £13m) of
restricted cash. This cash is held in respect of specific contracts
and can only be utilised in line with terms under the contractual
arrangements.
10. Derivative financial instrument
All
financial instruments held at fair value are classified by
reference to the source of inputs used to derive the fair value.
The following hierarchy is used:
|
Level 1 –
|
unadjusted
quoted prices in active markets for identical assets or
liabilities;
|
|
Level 2 –
|
inputs
other than quoted prices that are observable for the asset or
liability either directly as prices or indirectly through modelling
based on prices; and
|
|
Level 3 –
|
inputs
for the asset or liability that are not based on observable market
data.
|
|
Financial instrument
|
Hierarchy
level
|
Valuation method
|
|
Financial
assets traded in active markets
|
1
|
Current
bid price
|
|
Financial
liabilities traded in active markets
|
1
|
Current
ask price
|
|
Listed
bonds
|
1
|
Quoted
market prices
|
|
Money
market funds
|
1
|
Quoted
market prices
|
|
Interest
rate/currency swaps
|
2
|
Discounted
cash flow based on market swap rates
|
|
Forward
foreign exchange contracts
|
2
|
Forward
exchange market rates
|
|
Borrowings
not traded in active markets (term loans and uncommitted
facilities)
|
2
|
Nominal
value
|
|
Money
market deposits
|
2
|
Nominal
value
|
|
Trade
payables and receivables
|
2
|
Nominal
value less estimated credit adjustments
|
|
Contingent
consideration (including put option liability)
|
3
|
Discounted
cash flow using WACC
|
|
|
Fair value
assets
30 June 2023
£m
|
Fair
value
assets
31
December 2022
£m
|
Fair value
liabilities
30 June 2023
£m
|
Fair
value
liabilities
31
December 2022
£m
|
|
Interest
rate swaps (level 2):
|
|
|
|
|
|
–
non-hedge
|
–
|
–
|
(1)
|
–
|
|
–
cash flow hedge
|
47
|
36
|
(11)
|
(2)
|
|
–
net investment hedge
|
15
|
15
|
(73)
|
(120)
|
|
|
62
|
51
|
(85)
|
(122)
|
|
Analysed
as follows:
|
|
|
|
|
|
Current
portion
|
–
|
–
|
–
|
–
|
|
Non-current
portion
|
62
|
51
|
(85)
|
(122)
|
|
Derivative financial instruments
|
62
|
51
|
(85)
|
(122)
|
|
Contingent
consideration¹ (level 3)
|
–
|
–
|
(83)
|
(70)
|
|
Analysed
as follows:
|
|
|
|
|
|
Current
portion
|
–
|
–
|
(49)
|
(32)
|
|
Non-current
portion
|
–
|
–
|
(34)
|
(38)
|
|
Other payables (non-current)
|
–
|
–
|
(83)
|
(70)
|
1.
Contingent consideration includes put option liability of £40m
(2022: £45m).
Certain
interest rate swaps have been bifurcated to manage different
foreign exchange risks. The interest rate swaps are shown on the
balance sheet as net derivative assets £45m (2022: £21m)
and net derivative liabilities £68m (2022:
£92m).
Contingent
consideration includes liabilities for put options of £40m
(2022: £45m). The assumptions that are made in estimating the
value of the put option liabilities are option price and discount
rate. A 5% reduction in the estimated option price would result in
a £2m decrease in the liability, and a 100 basis point
decrease in the discount rate would result in a £1m increase
in the liability. All gains and losses relating to the put option
are recognised in OCI.
Given
the volume of acquisitions and the variety of inputs to the
valuation of contingent consideration (depending on each
transaction) there is not considered to be any change in input that
would have a material impact on the contingent consideration
liability.
|
|
Contingent
consideration
30 June 2023
£m
|
Contingent
consideration
30 June
2022
£m
|
|
At 1
January
|
70
|
75
|
|
Exchange
differences
|
(2)
|
2
|
|
Acquisitions
|
33
|
27
|
|
Payments
|
(15)
|
(13)
|
|
Revaluation
of put option through equity
|
(3)
|
(1)
|
|
|
83
|
90
|
Fair
value is equal to carrying value for all other trade and other
payables.
11. Analysis of bank and bond debt
Borrowings
are recognised initially at fair value, net of transaction costs
incurred. Borrowings are classified as current liabilities unless
the Group has a continuing right to defer settlement of the
liability for at least 12 months after the balance sheet
date.
The
Group’s bank debt comprises:
|
|
Facility
amount
at 30 June
2023
£m
|
Drawn at
period end
at 30 June 2023
£m
|
Headroom
at 30 June
2023
£m
|
Interest rate
at period end
at 30 June
2023
%
|
|
Non-current
|
|
|
|
|
|
$700m
term loan due October 2025
|
551
|
551
|
–
|
5.9
|
|
$1.0bn
RCF due October 2027
|
787
|
–
|
787
|
0.14
|
|
|
Facility
amount
at 31
December
2022
£m
|
Drawn
at
period
end
at 31
December
2022
£m
|
Headroom
at 31
December
2022
£m
|
Interest
rate at period end
at 31
December
2022
%
|
|
Non-current
|
|
|
|
|
|
$700m
term loan due October 2025
|
579
|
579
|
–
|
4.9
|
|
$1.0bn
RCF due October 2027
|
827
|
–
|
827
|
0.14
|
The
Group has a committed $1.0bn revolving credit facility (RCF) which
is available for cash drawings up to $1.0bn. The maturity date is
October 2027. As at 30 June 2023 the facility was undrawn (2022:
£nil).
Medium-term
notes and bond debt comprises:
|
|
Bond interest
coupon
2023
|
Effective hedged interest rate
2023
|
|
Non-current
|
|
|
|
€400m
bond due November 2024
|
Fixed 0.950%
|
Fixed 3.62%
|
|
€500m
bond due May 2026
|
Fixed 0.875%
|
Fixed 2.82%
|
|
€850m
bond due June 2027
|
Fixed 3.875%
|
Fixed 5.06%
|
|
€600m
bond due October 2028
|
Fixed 0.500%
|
Fixed 2.25%
|
|
€600m
bond due June 2030
|
Fixed 4.375%
|
Fixed 4.56%
|
|
£400m
bond due June 2032
|
Fixed 5.000%
|
Fixed 5.20%
|
|
Average cost of bond debt at period-end rates
|
4.00%
|
|
The
effective hedged interest rate reflects the interest rate payable
after the impact of interest due from cross-currency swaps. The
Group’s hedging strategy is to hold foreign currency debt in
proportion to foreign currency profit and cash flows, which are
mainly in euro and US dollar. As a result, the Group has swapped a
portion of the bonds it has issued into US dollars, thus increasing
the effective hedged interest rate.
The
Group has no significant concentration of credit risk. At 30 June
2023 the Group had a total of £23m of cash held on bank
accounts with banks rated below A- by S&P (2022: £36m).
The highest concentration with any single bank rated below A- was
£4m (2022: £14m).
The
Group considers the fair value of other current liabilities to be
equal to the carrying value.
12. Operating cash and Free Cash Flow
|
|
2023£m
|
2022£m
|
|
Operating
profit
|
304
|
170
|
|
Adjustments for:
|
|
|
|
–
Depreciation and impairment of property, plant and
equipment
|
75
|
65
|
|
–
Depreciation and impairment of leased assets
|
60
|
40
|
|
–
Amortisation and impairment of intangible assets (excluding
computer software)
|
87
|
40
|
|
–
Amortisation and impairment of computer software
|
12
|
9
|
|
–
Other non-cash items
|
18
|
3
|
|
Changes in working capital (excluding the effects of acquisitions
and exchange differences on consolidation):
|
|
|
|
–
Inventories
|
(15)
|
(22)
|
|
–
Contract costs
|
(5)
|
(3)
|
|
–
Trade and other receivables
|
(64)
|
(57)
|
|
–
Accrued income
|
9
|
7
|
|
–
Trade and other payables and provisions
|
3
|
47
|
|
–
Contract liabilities
|
20
|
13
|
|
Cash generated from operating activities
|
504
|
312
|
|
|
|
|
|
Purchase
of property, plant and equipment
|
(81)
|
(68)
|
|
Purchase
of intangible fixed assets
|
(21)
|
(15)
|
|
Capital
element of lease payments and initial direct costs
incurred
|
(81)
|
(45)
|
|
Proceeds
from sale of property, plant and equipment
|
2
|
3
|
|
Cash
impact of one-off and adjusting items
|
78
|
15
|
|
Adjusted Cash Flow
|
401
|
202
|
|
Interest
received
|
8
|
2
|
|
Interest
paid
|
(122)
|
(21)
|
|
Income
tax paid
|
(58)
|
(32)
|
|
Free Cash Flow
|
229
|
151
|
Free Cash Flow
The
Group aims to generate sustainable cash flow (Free Cash Flow) in
order to support its acquisition programme and to fund dividend
payments to shareholders. Free Cash Flow is measured as net cash
from operating activities, adjusted for cash flows related to the
purchase and sale of property, plant, equipment and intangible
fixed assets, cash flows related to leased assets, cash flows
related to one-off and adjusting items and dividends received from
associates. These items are considered by management to be
non-discretionary, as continued investment in these assets is
required to support the day-to-day operations of the business. A
reconciliation of Free Cash Flow from net cash from operating
activities is provided in the table below:
|
|
2023
AER
£m
|
2022
AER
£m
|
|
Net
cash from operating activities
|
332
|
261
|
|
Purchase
of property, plant, equipment and intangible fixed
assets
|
(102)
|
(83)
|
|
Capital
element of lease payments and initial direct costs
incurred
|
(81)
|
(45)
|
|
Proceeds
from sale of property, plant, equipment and software
|
2
|
3
|
|
Cash
impact of one-off and adjusting items
|
78
|
15
|
|
Dividends
received from associates
|
–
|
–
|
|
Free Cash Flow
|
229
|
151
|
Adjusted Free Cash Flow conversion
Adjusted
Free Cash Flow conversion is calculated by dividing Adjusted Free
Cash Flow by Adjusted Profit After Tax, expressed as a percentage.
Adjusted Free Cash Flow is measured as Free Cash Flow adjusted for
product development additions and net investment hedge cash
interest through Other Comprehensive Income.
|
|
2023
AER
£m
|
2022
AER
£m
|
|
Adjusted
Profit After Tax
|
289
|
177
|
|
Free
Cash Flow
|
229
|
151
|
|
Product
development additions
|
5
|
3
|
|
Net
investment hedge cash interest through Other Comprehensive
Income
|
6
|
4
|
|
Adjusted Free Cash Flow
|
240
|
158
|
|
Free Cash Flow conversion
|
83.0%
|
89.3%
|
13. Provisions for liabilities and charges
The
Group has provisions for termite damage claims, self-insurance,
environmental and other. Provisions are recognised when the Group
has a present obligation as a result of past events, it is probable
that an outflow of resources will be required to settle the
obligation, and the amount is capable of being reliably estimated.
If such an obligation is not capable of being reliably estimated it
is classified as a contingent liability.
|
|
Termite damage claims
£m
|
Self-
insurance
£m
|
Environmental
£m
|
Other
£m
|
Total
£m
|
|
At 1
January 2022
|
–
|
37
|
11
|
13
|
61
|
|
Exchange
differences
|
–
|
4
|
–
|
–
|
4
|
|
Additional
provisions
|
–
|
11
|
–
|
3
|
14
|
|
Used
during the period
|
–
|
(8)
|
(1)
|
(4)
|
(13)
|
|
At 30 June 2022
|
–
|
44
|
10
|
12
|
66
|
|
|
|
|
|
|
|
|
At 1
January 2023
|
303
|
165
|
12
|
12
|
492
|
|
Exchange
differences
|
(14)
|
(7)
|
(1)
|
–
|
(22)
|
|
Additional
provisions
|
8
|
28
|
3
|
3
|
42
|
|
Used
during the period
|
(37)
|
(25)
|
(1)
|
(3)
|
(66)
|
|
Unused
amounts reversed
|
–
|
(2)
|
–
|
(1)
|
(3)
|
|
Acquisition
of companies and businesses
|
–
|
–
|
3
|
2
|
5
|
|
Unwinding
of discount on provisions
|
6
|
–
|
–
|
–
|
6
|
|
At 30 June 2023
|
266
|
159
|
16
|
13
|
454
|
|
|
2023Total£m
|
2022Total£m
|
|
Analysed
as follows:
|
|
|
|
Non-current
|
329
|
39
|
|
Current
|
125
|
27
|
|
Total
|
454
|
66
|
Termite damage claims
The
Group holds provisions for termite damage claims covered by
contractual warranties. Termite damage claim provisions are subject
to significant assumptions and estimation uncertainty. The
assumptions included in valuing termite provisions are based on an
estimate of the rate and cost of future claims (based on historical
and forecast information), customer churn rates and discount rates.
These provisions are expected to be substantially utilised within
the next 20 years. The trend of volume and value of claims is
monitored and reviewed over time (with the support of external
advisers) and as such the value of the provisions are also likely
to change.
The
sensitivity of the liability balance to changes in the inputs is
illustrated as follows:
|
●
|
Discount
rate – this exposure is largely based within the United
States, therefore measurement is based on a US risk-free rate. As
we have seen during 2022 and 2023, interest rates (and therefore
discount rates) have moved up and are at their highest in over a
decade. Rates could move in either direction and management has
modelled that an increase/decrease of 5% in yields (from 4.31% to
4.53%) would reduce/increase the provision by £3m. Over the 6
months to 30 June 2023, risk free rates used for the provision have
remained broadly flat.
|
|
●
|
Claim
cost – claim cost forecasts have been based on the latest
available historical settled Terminix claims. Claims costs are
dependent on a range of inputs including labour cost, materials
costs (e.g. timber), whether a claim becomes litigated or not, and
specific circumstances including contributory factors at the
premises. Management has determined the historical time period for
each material category of claim, between six months and five years,
to determine an estimate for costs per claim. Recent fluctuations
in input prices (e.g. timber prices) means that there is potential
for volatility in claim costs and therefore future material changes
in provisions. Management has modelled that a structural increase/
decrease of 5% in total claim costs would increase/decrease the
provision by c.£15m. Over the 6 months to 30 June 2023, in
year costs per claim rose by c.5.6%.
|
|
●
|
Claim
rate – management has estimated claim rates based on
statistical historical incurred claims. Data has been captured and
analysed by a third party agency, used by Terminix over many years,
to establish incidence curves that can be used to estimate likely
future cash outflows. Changes in rates of claim are largely outside
the Group’s control and may depend on litigation trends
within the US, and other external factors such as how often
customers move property and how well they maintain those
properties. This causes estimation uncertainty that could lead to
material changes in provision measurement. Management has modelled
that an increase/decrease of 5% in overall claim rates would
increase/decrease the provision by c.£15m accordingly. Over
the 6 months to 30 June 2023 claim rates have been broadly
flat.
|
|
●
|
Customer
churn rate – If customers choose not to renew their contracts
each year, then the assurance warranty falls away. As such there is
sensitivity to the assumption on how many customers will churn out
of the portfolio of customers each year. Data has been captured and
analysed by a third party agency, used by Terminix over many years,
to establish incidence curves for customer churn, and forward
looking assumptions have been made based on these curves. Changes
in churn rates are subject to macro-economic factors and to the
performance of the Group. A 1% movement in customer churn rates, up
or down, would change the provision by c.£10m up or down,
accordingly. On average over the last 10 years annualised churn
rates move by +/- c.1.2% per annum.
|
Self-insurance
The
Group purchases external insurance from a portfolio of
international insurers for its key insurable risks, mainly
employee-related risks. Self-insured deductibles within these
insurance policies have changed over time due to external market
conditions and scale of operations. These provisions represent
obligations for open claims and are estimated based on
actuarial/management’s assessment at the balance sheet date.
The Group expects to continue self-insuring the same level of risks
and estimates that 50% to 75% of claims should settle within the
next five years.
Environmental
The
Group owns a number of properties in Europe and the US where there
may be environmental contamination. These issues tend to be complex
to determine and resolve, and may be material although are often
not possible to measure reliably. Where issues are known and
reliably measurable, provisions are held for the remediation of any
contamination. Contingent liabilities exist where the conditions
for recognising a provision under IAS 37 have not been met. The
Group monitors such properties to determine whether further
provisions are necessary. The provisions that have been recognised
are expected to be substantially utilised within the next five
years.
Other
Other
provisions principally comprise amounts required to cover
obligations arising and costs relating to disposed businesses and
restructuring costs. Other provisions also includes costs relating
to properties the Group no longer occupies such as security,
utilities and insurance. Existing provisions are expected to be
substantially utilised within the next five years.
14. Post balance sheet events
There
have been no significant post balance sheet events affecting the
Group since 30 June 2023.
15. Legal statements
The
financial information for the six month period ended 30 June 2023
contained in this interim announcement has been approved by the
Board and authorised for release on 27 July 2023.
These
condensed interim financial statements do not comprise statutory
accounts within the meaning of section 434 of the Companies Act
2006. Statutory accounts for the year 31 December 2022 were
approved by the Board of Directors and authorised for release on 16
March 2023 and delivered to the Registrar of Companies. The report
of the auditors on those accounts was (i) unqualified, (ii) did not
include a reference to any matters to which the auditors drew
attention by way of emphasis without qualifying their report and
(iii) did not contain a statement under section 498 (2) or (3) of
the Companies Act 2006.
The
directors of Rentokil Initial plc are listed in the Rentokil
Initial plc Annual Report for 31 December 2022. A list of the
current directors is maintained on the Rentokil Initial website:
rentokil-initial.com.
Responsibility statement of the directors in respect of the 2023
interim statement
We
confirm that to the best of our knowledge:
|
●
|
the
condensed set of financial statements prepared in accordance with
IAS 34, 'Internal Financial Reporting', as adopted in the UK (IAS
34), gives a true and fair view of the assets, liabilities,
financial position and profit or loss of the Company and its
subsidiaries included in the consolidation as a whole as required
by DTR 4.2.4R; and
|
|
●
|
the
interim management report includes a fair review of the information
required by DTR 4.2.7R of the Disclosure Guidance and Transparency
Rules, being an indication of important events that have occurred
during the first six months of the financial year and their impact
on the condensed set of financial statements; and a description of
the principal risks and uncertainties for the remaining six months
of the year.
|
We have
reviewed, and found that we have nothing to report in relation to
the requirements of DTR 4.2.8R of the Disclosure Guidance and
Transparency Rules, being related party transactions that have
taken place in the first six months of the current financial year
and that have materially affected the financial position or
performance of the entity during that period; and any changes in
the related party transactions described in the last annual report
that could do so.
By
Order of the Board
Andy
Ransom
Chief
Executive
27 July
2023
Independent review report to Rentokil Initial plc
Report on the condensed consolidated interim financial
statements
Our conclusion
We have
reviewed Rentokil Initial plc’s condensed consolidated
interim financial statements (the “interim financial
statements”) in the 2023 Interim Results of Rentokil Initial
plc for the six month period ended 30 June 2023 (the
“period”).
Based
on our review, nothing has come to our attention that causes us to
believe that the interim financial statements are not prepared, in
all material respects, in accordance with UK adopted International
Accounting Standard 34, 'Interim Financial Reporting' and the
Disclosure Guidance and Transparency Rules sourcebook of the United
Kingdom’s Financial Conduct Authority.
The
interim financial statements comprise:
|
●
|
the
consolidated Balance Sheet as at 30 June 2023;
|
|
●
|
the
consolidated Statement of Profit or Loss and Other Comprehensive
Income for the period then ended;
|
|
●
|
the
consolidated Cash Flow Statement for the period then
ended;
|
|
●
|
the
consolidated Statement of Changes in Equity for the period then
ended; and
|
|
●
|
the
explanatory notes to the interim financial statements.
|
The
interim financial statements included in the 2023 Interim Results
of Rentokil Initial plc have been prepared in accordance with UK
adopted International Accounting Standard 34, 'Interim Financial
Reporting' and the Disclosure Guidance and Transparency Rules
sourcebook of the United Kingdom’s Financial Conduct
Authority.
Basis for conclusion
We
conducted our review in accordance with International Standard on
Review Engagements (UK) 2410, ‘Review of Interim Financial
Information Performed by the Independent Auditor of the
Entity’ issued by the Financial Reporting Council for use in
the United Kingdom (“ISRE (UK) 2410”). A review of
interim financial information consists of making enquiries,
primarily of persons responsible for financial and accounting
matters, and applying analytical and other review
procedures.
A
review is substantially less in scope than an audit conducted in
accordance with International Standards on Auditing (UK) and,
consequently, does not enable us to obtain assurance that we would
become aware of all significant matters that might be identified in
an audit. Accordingly, we do not express an audit
opinion.
We have
read the other information contained in the 2023 Interim Results
and considered whether it contains any apparent misstatements or
material inconsistencies with the information in the interim
financial statements.
Conclusions relating to going concern
Based
on our review procedures, which are less extensive than those
performed in an audit as described in the Basis for conclusion
section of this report, nothing has come to our attention to
suggest that the directors have inappropriately adopted the going
concern basis of accounting or that the directors have identified
material uncertainties relating to going concern that are not
appropriately disclosed. This conclusion is based on the review
procedures performed in accordance with ISRE (UK) 2410. However,
future events or conditions may cause the group to cease to
continue as a going concern.
Responsibilities for the interim financial statements and the
review
Our responsibilities and those of the directors
The
2023 Interim Results, including the interim financial statements,
is the responsibility of, and has been approved by the directors.
The directors are responsible for preparing the 2023 Interim
Results in accordance with the Disclosure Guidance and Transparency
Rules sourcebook of the United Kingdom’s Financial Conduct
Authority. In preparing the 2023 Interim Results, including the
interim financial statements, the directors are responsible for
assessing the group’s ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and
using the going concern basis of accounting unless the directors
either intend to liquidate the group or to cease operations, or
have no realistic alternative but to do so.
Our
responsibility is to express a conclusion on the interim financial
statements in the 2023 Interim Results based on our review. Our
conclusion, including our Conclusions relating to going concern, is
based on procedures that are less extensive than audit procedures,
as described in the Basis for conclusion paragraph of this report.
This report, including the conclusion, has been prepared for and
only for the company for the purpose of complying with the
Disclosure Guidance and Transparency Rules sourcebook of the United
Kingdom’s Financial Conduct Authority and for no other
purpose. We do not, in giving this conclusion, accept or assume
responsibility for any other purpose or to any other person to whom
this report is shown or into whose hands it may come save where
expressly agreed by our prior consent in writing.
PricewaterhouseCoopers
LLP
Chartered
Accountants
London
27 July
2023
Cautionary statement
In
order to utilise the ‘safe harbour’ provisions of the
U.S. Private Securities Litigation Reform Act of 1995 (the
“PSLRA”) and the general doctrine of cautionary
statements, Rentokil Initial plc (“the Company”) is
providing the following cautionary statement: This communication
contains forward-looking statements within the meaning of the
PSLRA. Forward-looking statements can sometimes, but not always, be
identified by the use of forward-looking terms such as
“believes,” “expects,” “may,”
“will,” “shall,” “should,”
“would,” “could,” “potential,”
“seeks,” “aims,” “projects,”
“predicts,” “is optimistic,”
“intends,” “plans,”
“estimates,” “targets,”
“anticipates,” “continues” or other
comparable terms or negatives of these terms and include statements
regarding Rentokil Initial’s intentions, beliefs or current
expectations concerning, amongst other things, the results of
operations of the Company and its consolidated entities
(“Rentokil Initial” or “the Group”),
financial condition, liquidity, prospects, growth, strategies and
the economic and business circumstances occurring from time to time
in the countries and markets in which Rentokil Initial operates.
Forward-looking statements are based upon current plans, estimates
and expectations that are subject to risks, uncertainties and
assumptions. Should one or more of these risks or uncertainties
materialise, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated or
anticipated by such forward-looking statements. The Company can
give no assurance that such plans, estimates or expectations will
be achieved and therefore, actual results may differ materially
from any plans, estimates or expectations in such forward-looking
statements. Important factors that could cause actual results to
differ materially from such plans, estimates or expectations
include: the Group’s ability to integrate acquisitions
successfully, or any unexpected costs or liabilities from the
Group’s disposals; difficulties in integrating, streamlining
and optimising the Group’s IT systems, processes and
technologies; the availability of a suitably skilled and qualified
labour force to maintain the Group’s business; the
Group’s ability to attract, retain and develop key personnel
to lead the business; the impact of environmental, social and
governance (“ESG”) matters, including those related to
climate change and sustainability, on the Group’s business,
reputation, results of operations, financial condition and/or
prospects; inflationary pressures, such as increases in wages, fuel
prices and other operating costs; supply chain issues, which may
result in product shortages or other disruptions to the
Group’s business; weakening general economic conditions,
including changes in the global job market or decreased consumer
confidence or spending levels; the Group’s ability to
implement its business strategies successfully, including achieving
its growth objectives; the Group’s ability to retain existing
customers and attract new customers; the highly competitive nature
of the Group’s industries; cybersecurity breaches, attacks
and other similar incidents; extraordinary events that impact the
Group’s ability to service customers without interruption,
including a loss of its third-party distributors; the Group’s
ability to protect its intellectual property and other proprietary
rights that are material to the Group’s business; the
Group’s reliance on third parties, including third-party
vendors for business process outsourcing initiatives, investment
counterparties, and franchisees, and the risk of any termination or
disruption of such relationships or counterparty default or
litigation; failure to maintain effective internal control over
financial reporting in accordance with Section 404 of the
Sarbanes-Oxley Act; any future impairment charges, asset
revaluations or downgrades; failure to comply with the many laws
and governmental regulations to which the Group is subject or the
implementation of any new or revised laws or regulations that alter
the environment in which the Group does business, as well as the
costs to the Group of complying with any such changes; termite
damage claims and lawsuits related thereto; the Group’s
ability to comply with safety, health and environmental policies,
laws and regulations, including laws pertaining to the use of
pesticides; any actual or perceived failure to comply with
stringent, complex and evolving laws, rules, regulations and
standards, as well as contractual obligations, relating to data
privacy and security; changes in tax laws and any unanticipated tax
liabilities; adverse credit and financial market events and
conditions, which could, among other things, impede access to or
increase the cost of financing; the restrictions and limitations
within the agreements and instruments governing our indebtedness; a
lowering or withdrawal of the ratings, outlook or watch assigned to
the Group’s debt securities by rating agencies; an increase
in interest rates and the resulting increase in the cost of
servicing the Group’s debt; and exchange rate fluctuations
and the impact on the Group’s results or the foreign currency
value of the Company’s ADSs and any dividends. The list of
factors presented here is representative and should not be
considered to be a complete statement of all potential risks and
uncertainties. Unlisted factors may present significant additional
obstacles to the realisation of forward-looking statements. The
Company cautions you not to place undue reliance on any of these
forward-looking statements as they are not guarantees of future
performance or outcomes and that actual performance and outcomes,
including, without limitation, the Group’s actual results of
operations, financial condition and liquidity, and the development
of new markets or market segments in which the Group operates, may
differ materially from those made in or suggested by the
forward-looking statements contained in this communication. Except
as required by law, Rentokil Initial assumes no obligation to
update or revise the information contained herein, which speaks
only as of the date hereof.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Date:
27 July 2023
|
RENTOKIL INITIAL PLC
|
|
|
/s/
Stuart
Ingall-Tombs
|
|
|
Name:
Stuart Ingall-Tombs
|
|
|
Title:
Chief Financial Officer
|
|
|
|